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ABSTRACT 
 
Background: Reflux of gastric contents in gastric fed patients is a contributor to pulmonary 
aspiration. Aspiration events are reported in approximately 50-75% of patients with endotracheal 
tubes.
 
Aspiration of oral and gastric secretions in ventilated patients is a major cause of ventilator 
associated pneumonia (VAP). Guidelines that recommend head of bed (HOB) elevation greater 
than 30
◦
 to prevent reflux, aspiration and VAP conflict with guidelines to prevent pressure ulcers 
which recommend HOB elevation no greater than 30
◦
. Studies are lacking on direct comparison 
of HOB elevation at 30
◦
and 45
◦
 for reflux, aspiration and pressure ulcer outcomes simultaneously. 
Esophageal probe pH measures are used to detect reflux. No studies have examined the 
predictive relationship of reflux and aspiration in mechanically ventilated gastric fed patients or 
the role of pH measurement at the bedside with pH paper to detect gastric reflux. 
Purpose: This study had 6 aims: 1) To describe the frequency and duration to which patients’ 
HOB angles are temporarily lowered for treatment purposes below 30
◦
 or below 45
◦
, 2) To 
describe the occurrence of reflux (pepsin-positive oral secretions) and aspiration (pepsin-positive 
tracheal secretions) with HOB elevation at 30
◦
 and 45
◦
, 3) To determine the association between 
reflux and aspiration with the 2 different HOB elevations in adult intensive care unit (ICU) 
mechanically ventilated gastric fed patients,  4) To determine the association between a 
temporarily lowered HOB position for treatment purposes and reflux of gastric contents, 5) To 
determine the association between 7 patient characteristics (gender, age, body mass index, 
gastric residual volume, sedation level, disease severity, and use of prokinetic agents) and reflux, 
6)  To determine the association between the pH (range 0-14) of oral secretions and pepsin 
presence in oral secretions. 
  
  
iv 
Methodology: Human Research Protection Office approval was obtained. Consent was acquired 
from patient surrogates the day prior to enrollment in the study. A randomized 2-day crossover 
trial was conducted in a surgical and medical ICU. Mechanically ventilated gastric fed subjects 
were randomly assigned to 1 of the 2 HOB elevation sequences, HOB 30
◦
 for 12 hours (hrs) on 
day 1 and 45
◦
 for 12 hrs on day 2 or HOB at 45
◦
 for 12 hrs on day 1 and 30
◦
 for 12 hrs on day 2. 
A HOB measurement device stored HOB angles every 30 seconds over the 36 hrs. Subject 
preferences for positioning for comfort were considered and HOB was lowered at any time by 
clinicians as the clinical situation warranted or during procedures and diagnostic tests. Usual care 
for the elevation of the HOB was considered 30
◦
 and experimental was 45
◦
. Oral secretions were 
obtained hourly or as needed and tracheal secretions every 2 hrs or as needed. All samples of oral 
secretions were examined for the presence of pepsin and pH measurement. Subjects were 
repositioned every 2 hrs as their condition allowed. Skin assessment of sacral/coccyx and greater 
trochanter areas were assessed for pressure ulcers every 2 hrs with each reposition. Data were 
analyzed using Wilcoxon Signed Rank Tests, Friedman tests for repeated measures and 
Kendall’s tau correlations. 
Results: Fifteen subjects were enrolled; 11 subjects completed both days, 4 subjects had 
partial data collection due to endotracheal tube removal. The total number of hrs was 150 hrs at 
30
◦
 and 160 hrs at 45
◦
. No subjects developed pressure ulcers per National Pressure Ulcer 
Advisory Panel staging guidelines. Subjects were maintained at 30
◦
 for 96% of possible minutes 
and at 45
◦
 for 77% of possible minutes (p = .035). The mean HOB angle when lowered was 8.2
◦
 
in the 30
◦
 condition and 19.4
◦
 in the 45
◦
 condition (p = .008). Subjects’ HOB angles were lowered 
66 times (mean = 4.7/patient) in the 30
◦
 hrs and 76 times (mean = 5/patient) in the 45
◦
 hrs. 
Overall mean angle for HOB was 30
◦
 for usual care hrs and 39
◦
 for the experimental hrs. A total 
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of 188 oral secretions were obtained, 106 (56%) were pepsin-negative and 82 (44%) were 
pepsin-positive. A total of 174 tracheal secretions were obtained, 66 (38%) were pepsin-negative 
and 108 (62%) were pepsin-positive. No significant association was found with the minutes the 
HOB was lowered or the mean angle when lowered and percent pepsin-positive oral secretions. 
Mean HOB angle on each day was significantly negatively correlated with percent pepsin-
positive oral secretions. The mean percent of pepsin-positive oral secretions was not significantly 
higher (p=.108) at 30
◦
 HOB elevation (48.4 ± 31.3) compared to 45
◦
 HOB elevation (32.3 ± 33.2). 
The mean percent of pepsin-positive tracheal secretions was not significantly higher (p = .366) at 
30
◦
 HOB elevation (69.4 ± 33.8) than 45
◦
 HOB elevation (62.5 ± 34.5). The median frequency 
that oral secretions were obtained, (mean, SD, median) 8.5 ± 3.6, 9.5 at 30
◦
 and 5.7 ± 3.2, 5, at 
45
◦
, was significantly lower at 45
◦
 (p = .035). The only significant patient characteristic in 
relationship to the percent of pepsin-positive oral secretions was deeper sedation. No relationship 
between reflux and aspiration or pH measures and reflux were found.  
Conclusions: With the cross over design of 15 subjects, the number of oral and tracheal 
specimens collected provided over 360 samples. Lower mean HOB angles as well as deeper 
sedation levels were associated with a significantly higher frequency of reflux. Results of this 
study provide evidence that HOB positioning > 30
◦
 is feasible and superior to HOB ≤ 30
◦
 in 
mechanically ventilated gastric fed ICU patients to reduce reflux and aspiration without 
development of pressure ulcers. 
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INTRODUCTION 
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Gastric Reflux and Aspiration 
As a result of their primary illness or injury and need for mechanical ventilation, 
intensive care unit (ICU) patients often cannot consume nutritional requirements by mouth. 
Therefore, many patients require feeding tubes for nutrition and hydration. Gastric feeding is 
used most frequently as the initial site for feeding, although it is associated with a greater risk for 
gastroesophageal reflux (GER) of gastric contents. GER is associated with tube feedings for a 
variety of reasons such as gastric distention, and tubes traversing the esophageal sphincters. In 
addition, pulmonary aspiration of gastric content can lead to pneumonia.
1
    
GER refers to the passage of gastric contents into the esophagus. In most people, GER is 
a normal physiologic process occurring a few times a day. In contrast, patients with 
gastroesophageal reflux disease (GERD) experience frequent and abnormal amounts of GER 
which can lead to esophageal mucosal injury.
 
Additionally, long term GERD is associated with 
Barrett esophagus which increases the risk of esophageal cancer.
2 
Extraesophageal reflux (EER) 
refers to the passage of gastric contents in extraesophageal areas including the pharynx, oral 
cavity, larynx and upper airway above the vocal cords.
3
 EER is linked to asthma, posterior 
laryngitis, chronic coughing, pharyngitis,
4-5 
and middle ear and upper respiratory tract infection.
6-
7  
In the ICU setting, GER and EER are generally not measured or detected unless large amounts 
of gastric secretions are visualized in the oral cavity by health care providers.  
Aspiration represents inhalation of material (oral or gastric) into the airway below the 
level of the vocal cords. Aspiration is the leading cause of pneumonia and results in significant 
morbidity and mortality across a variety of settings.
8
 Pulmonary aspiration of gastric secretions 
resulting in aspiration pneumonia and aspiration pneumonitis have been reported in the 
community setting,
8
 in pre-hospital emergency situations,
9
 in a variety of hospitalized patients on 
  
  
3 
medical-surgical divisions,
10
 in critically ill neonate, pediatric
4, 11-12
 and adult patients
13-14 
and in 
anesthesia situations.
15
  
Critically ill patients often have a decreased level of consciousness which impairs the gag 
reflex and leads to pooling of oral secretions in the posterior oropharynx. In patients with an 
endotracheal tube, a direct pathway is available for these secretions to enter the lungs.
16
 
Aspiration events are reported in approximately 50-75% of patients with endotracheal tubes.
10 
Aspiration of oral and gastric secretions in ventilated patients is a major cause of ventilator 
associated pneumonia (VAP).
14
 VAP is one of the most common hospital-acquired infection in 
critically ill patients with a reported incidence of 10-40%.
17-18
 VAP is associated with an 
increased length of mechanical ventilation, ICU and hospital length of stay as well as increased 
mortality. Each case of VAP is estimated to increase hospital costs by $40,000-$50,000.
18 
Critical care nurses provide interventions to prevent complications. However, at times 
nurses must balance the prevention of one potential complication against the prevention of other 
complications.
19-20
 Several guidelines aim to reduce the complications of reflux, aspiration and 
VAP. Generally, VAP prevention interventions include recommendations for the head of bed 
(HOB) elevation to be maintained greater than 30 degrees (
◦
) and as high as 45
◦
 when possible.  
Organizations recommending HOB elevation greater than 30
◦
 include: 1) the Centers for Disease 
Control (CDC),
21
 2) the American Association of Critical Care Nurses (AACN),
22
 3) American 
Society for Parenteral and Enteral Nutrition (ASPEN),
1
 4) Canadian Critical Care Trials Group,
23
 
and 5) a joint guideline from ASPEN and the Society of Critical Care Medicine (SCCM).
24
 
Conversely, risk of pressure ulcer development increases with HOB elevation above 30
◦ 
due to increased pressure load to the sacral area in semi-recumbent and lateral positioning.
25-26
 
Clinical practice guidelines on pressure ulcer reduction encourage limitation of HOB elevation in 
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semi-recumbent or side lying positions.
27-28
 In addition, many factors such as patient 
hemodynamic instability, patient comfort, and patient surgical or medical history may preclude 
the ability to maintain 30-45
◦
 HOB elevation.  
Statement of Problem 
Large-volume aspirations following vomiting occur infrequently and are often 
unwitnessed by clinicians.
29
 However, microaspirations occur frequently in gastric fed patients.
14
 
Nurses are often not aware that a patient is experiencing reflux thus increasing the risk for 
aspiration. No studies have examined the predictive relationship of reflux and aspiration in 
mechanically ventilated gastric fed patients. Additionally, guidelines that recommend HOB 
elevation greater than 30
◦
 to prevent reflux and aspiration conflict with guidelines to prevent 
pressure ulcers which recommend HOB elevation no greater than 30
◦
. Therefore, research is 
needed to study the difference in the incidence of GER with 30
◦
 compared to 45
◦
 HOB elevations. 
Obtaining oral secretions is easier and less stressful for the patient than obtaining tracheal 
secretions. A simple pH measurement of oral secretions has not been studied in the mechanically 
ventilated gastric fed patient as a potential marker for reflux in this population. If reflux episodes 
could be detected, association with aspiration determined and risk factors identified, nurses could 
be better informed to make HOB position decisions.  
Significance 
With the high incidence of aspiration in critically ill mechanically ventilated gastric fed 
patients, interventions to reduce the incidence of aspiration could lead to a significant decrease in 
VAP. Elimination or reduction of hospital acquired infections such as VAP is a priority of the 
CDC,
21
 the Institute of Medicine,
30
 and the Joint Commission.
31
 Critical care nurses can play a 
crucial role in the identification of patients at risk for GER and aspiration and intervene to reduce 
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the patient’s risk with interventions such as positioning the HOB.  
Research is needed to understand the relationship of reflux and aspiration in ICU patients 
and to further explore risk factors of reflux associated with subsequent aspiration. With 
identification of these risk factors for reflux and aspiration, nurse researchers can develop and 
study new therapies to reduce the risk of aspiration and therefore prevent airway and lung injury. 
Complications associated with aspiration could be greatly reduced with clinician implementation 
of best practices to reduce aspiration and VAP. These interventions could lead to reduced 
mortality for ICU patients, fewer ventilator days, fewer ICU and hospital days, significantly less 
suffering for patients and significant health care cost savings. Lastly, research on this topic may 
also provide evidence for interventions related to reflux for high risk patients in the peri-
operative, long-term care and out-patient settings. 
Aims and Research Questions 
Below are the 6 aims for this study with one research question associated with each aim. 
 1) To describe the frequency and duration to which patients’ HOB angles are temporarily 
lowered for treatment purposes below 30
◦
 or below 45
◦
. What is the frequency and extent to 
which the patient’s HOB is temporarily lowered for treatment purposes below 30
◦
 or below 45
◦
 
and overall mean HOB elevation in adult mechanically ventilated gastric fed ICU patients?  
2) To describe the occurrence of reflux (pepsin-positive oral secretions) and aspiration 
(pepsin-positive tracheal secretions) with HOB elevation at 30
◦
 and 45
◦
.  How often does reflux 
(pepsin positive oral secretions) and pulmonary aspiration of gastric contents (pepsin positive 
tracheal secretions) occur with HOB elevation at 30
◦
 and 45
◦
 in adult mechanically ventilated 
gastric fed ICU patients?   
  3) To determine the association between reflux and aspiration with the 2 different HOB 
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elevations in adult ICU mechanically ventilated gastric fed patients. What is the association 
between reflux (pepsin positive oral secretions) and aspiration (pepsin positive tracheal 
secretions) with HOB elevation at 30
◦
 and 45
◦ 
in adult mechanically ventilated gastric fed ICU 
patients?   
4) To determine the association between a temporarily lowered HOB position for 
treatment purposes and reflux of gastric contents. What is the association between a temporarily 
lowered HOB position for treatment purposes (minutes lowered, mean when lowered and overall 
mean) and reflux (pepsin positive oral secretions) in adult mechanically ventilated gastric fed 
ICU patients?   
5) To determine the association between 7 patient characteristics (gender, age, body mass 
index, gastric residual volume, sedation level, disease severity, and use of prokinetic agents) and 
reflux. What is the association between the following variables and reflux in adult mechanically 
ventilated gastric fed ICU patients?  
 Gender 
 Age  
 Body Mass Index (BMI)  
 Gastric residual volumes (GRV)  
 Sedation levels (Richmond-Agitation Sedation Scale) 
 Disease severity (APACHE II ) 
 Prokinetic agents  
6)  To determine the association between the pH (range 0-14) of oral secretions and 
pepsin presence in oral secretions (the gold standard measure of reflux). What is the association 
between the pH (range 0-14) of oral secretions and presence/absence of pepsin in oral secretions 
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in adult mechanically ventilated gastric fed ICU patients? 
Definition of Terms 
The conceptual and operational definitions used in this proposal are listed below.  
Gastroesophageal Reflux (GER) 
Conceptual Definition: Gastroesophageal reflux is the movement of gastric contents into the 
esophagus.
4
  
Operational Definition: Pepsin positive oral secretions obtained with a Yankauer suction device 
inserted into the oral cavity of ventilated ICU patients. 
Extraesophageal Reflux (EER) 
Conceptual Definition: Extraesophageal reflux is the retrograde flow of gastric contents to the 
pharynx, larynx and airway above the vocal cords.
3
  
Operational Definition: Pepsin positive oral secretions obtained with a Yankauer suction device 
inserted into the oral cavity of the subjects. 
Reflux 
Conceptual Definition: Reflux encompasses the movement of gastric contents either to the 
esophagus or extraesophageal regions. 
Operational Definition: Pepsin positive oral secretions obtained with a Yankauer suction device 
inserted into the oral cavity of the subjects. 
Aspiration  
Conceptual Definition: Aspiration is the inhalation of material (oral or gastric) into the airway 
below the level of the true vocal cords.
1
  
Operational Definition: Pepsin positive tracheal secretions obtained via endotracheal tube 
suctioning with a suction catheter advanced down the artificial airway. 
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Microaspiration  
Conceptual Definition: Microaspiration is the aspiration of a small volume of gastric or oral 
material that is generally not detected clinically.
1
  
Operational Definition: Pepsin positive tracheal secretions obtained via endotracheal tube 
suctioning with a suction catheter. 
Macroaspiration  
Conceptual Definition: Aspiration of a large volume of material that is generally detected 
clinically represents macroaspiration.
 1
  
Operational Definition: Witnessed vomiting of gastric contents by subjects or gastric contents 
observed in oral cavity of subjects which leads to pepsin positive tracheal secretions.  
Head of Bed Elevation (HOB) 
Conceptual Definition: HOB elevation is the extent to which the top portion of a hospital bed is 
elevated above or below zero degrees. 
Operational Definition: Degrees of elevation of the HOB above or below zero obtained from a 
calibrated electronic gauge placed on the bed frame of the subjects in the ICU.  
pH 
Conceptual Definition: A measure of the acidity or basicity of a solution 
Operational Definition: The pH of oral secretions measured with pH Hydrion paper with a range 
of 0-14. 
Gastric Residual Volume (GRV) 
Conceptual Definition: GRV is the volume in the stomach prior to the next bolus tube feeding or 
the amount in the stomach measured every 4 hrs with continuous gastric feeding. 
Operational Definition: The amount of gastric secretions removed from the subjects after 
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instillation of 30 ml of air into the irrigation port of the gastric feeding tube with a 60 ml catheter 
tipped syringe and application of negative pressure to the syringe until no further aspirate can be 
obtained.
14
  
Body Mass Index (BMI)  
Conceptual Definition: Calculated from a patient’s weight and height, BMI is a reliable indicator 
of a level of fatness for most people. BMI places patients in various weight categories such as 
normal, under or overweight using a simple number. 
Operational Definition: Body weight in kilograms divided by the square of height in meters 
(kg/m
2
). 
Prokinetics 
Conceptual Definition: Prokinetics are medications that stimulate gastrointestinal smooth muscle 
contractions.
24
  
Operational Definition: Medications, metoclopramide and erythromycin, which stimulate gastric 
contractions and enhance gastric emptying. 
Yankauer suction device   
Conceptual Definition: A Yankauer suction device is a suction device with a tip that has large 
openings surrounded by a bulbous head which is designed to allow effective suction of the 
oropharyngeal areas without damaging surrounding tissue.  
Operational Definition: An oral suctioning tool used by clinicians to suction oropharyngeal 
secretions in order to prevent aspiration. 
Washout Period 
Conceptual Definition: A washout period is the time between treatment periods in a crossover 
design study used to minimize carry over effects from the first treatment . 
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Operational Definition: Night time 12-hr period between day 1 and day 2 of data collection 
during which the subject’s bedside nurse determined HOB angle and positioning. 
Conceptual Model 
 A conceptual schema was designed to provide a framework for this study. Variables for 
the study were identified in the literature review and will be discussed in Chapter II. Figure 1 
depicts the independent variables of the two different HOB elevations and association with the 
dependent variables, reflux and aspiration, as detected by pepsin positive oral or tracheal 
secretions. HOB elevation of 30
◦
 and 45
◦
 was studied to describe the extent of reflux and 
aspiration and to determine the association between reflux and aspiration at the two different 
HOB elevations. In addition, variables associated with reflux, decreased HOB for treatment 
purposes and the patient variables identified in the literature review (age, gender, gastric residual 
volume, sedation level, disease severity and use of prokinetics) are presented in relationship to 
the different HOB elevations. The association of these variables with reflux was examined in this 
study. In addition, Figure 1 illustrates the study of the association of pH of oral secretions and 
pepsin presence in oral secretions. This study examined the association between pH of oral 
secretions and pepsin presence in oral secretions to determine the utility of pH measurement as a 
marker of reflux in the ICU mechanically ventilated gastric fed patient. 
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Figure 1  
Conceptual Model of Variables Thought to be Associated with Reflux and Aspiration  
 
 
 
 
 
Assumptions 
1. Pepsin was measured in a quantifiable way that was accurate and reproducible when using a 
western blot analysis.  
2. Western blot immunoassay is susceptible to pre-analytical and analytical variations. Thus, all 
oral and tracheal secretions were measured after careful calibration and quality control 
measures of the Criterion PAGE gel apparatus (Bio-Rad Labs; Hercules, CA) and the 
blotting apparatus (Thermo Scientific Owl; Asheville, NC), per manufacturer 
recommendations.    
ICU Mechanically Ventilated 
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HOB 
ELEVATION 
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presence in 
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between pepsin positive 
oral and pepsin positive 
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oral and pepsin positive 
tracheal secretions 
 
 
 
Variables 
Associated 
with Reflux 
Question 5: 
Gender 
Age 
BMI 
GRV 
RASS 
APACHE II 
Prokinetics 
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3. All collectors and processors of oral and tracheal secretions obtained, stored and prepared the 
specimens using an established standard protocol.  
4. Measurement of pH was measured on calibrated pH paper and all readers had the ability to 
visualize the full range of the color spectrum from a pH of 0 through a pH of 14. 
5. Measurement of the HOB elevation was conducted with a calibrated and accurate gauge that 
ranges from -20 to + 90 degrees placed on the bed frame. 
6. Measurement of sedation with the RASS sedation scale by ICU nurses was reliable with 
acceptable nurse-nurse inter-rater reliability.  
7. Measurement of gastric residual volume was performed by all data collectors using an 
established study protocol. 
8. Participants who were enrolled in the study represented the general population of adult 
critically ill mechanically ventilated gastric fed patients. 
9. Demographic (age, gender, admitting diagnosis) and APACHE II score variables derived 
from the EMR (EMR) were accurate. 
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Anatomy and Physiology of Normal Food Passage  
Through the Upper Gastrointestinal Tract 
Swallowing 
In the mouth, the digestion of food begins with mechanical breakdown from chewing and 
initial enzymatic digestion with salivary secretion. Saliva is comprised of a serous and a mucus 
portion. The serous secretion contains ptyalin an -amylase. Mucus lubricates the food and 
protects surfaces of the oral cavity.
33
 Mucus lubrication of the food facilitates swallowing.
34
 The 
oral cavity, pharynx, and larynx transfer food from the palate to the esophagus. Muscle groups of 
the soft palate, tongue and pharynx participate in swallowing while extrinsic muscles of the 
pharynx elevate and pull the pharynx forward to seal the laryngeal inlet during swallowing. 
Laryngeal movement during swallowing is essential to the swallowing mechanics necessary to 
close the airway as the food bolus moves from the pharynx to the esophagus.
35
 
Esophagus  
Anatomical features of the esophagus distinguish it from the remainder of the 
gastrointestinal tract. As a continuation of the oropharynx, the upper esophageal sphincter (UES) 
and upper 5% of the esophagus is composed of striated muscle and is under control of the 
cerebral cortex and medulla. The middle 35-40% of the esophagus is a combination of striated 
and smooth muscle with the smooth muscle proportion increasing distally. The distal 50-60% of 
the esophagus is entirely smooth muscle under the control of the vagus nerve and the enteric 
nervous system. The normal esophagus demonstrates no spontaneous contraction at rest with a 
pressure reflecting pleural pressure. The intensity and progression of esophageal peristalsis 
occurs in distinct zones because of the anatomical muscular pattern of the esophagus. Primary 
peristalsis of the esophagus begins with swallowing while secondary peristalsis can be initiated 
in response to esophageal distention with air or fluid. Low peristaltic amplitude, slight delay in 
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progression and an increased chance of failed transmission of peristalsis is found at the transition 
zone between the striated and smooth muscle segments.
35
 
Esophageal Sphincters 
When closed, the upper esophageal sphincter (UES) has a slit-like configuration.  The 
UES must maintain closure to prevent refluxed material from reaching the pharynx. UES closure 
also prevents air from entering the esophagus during inspiration. The UES opens when 
swallowing or belching is required.
36-37
 
The lower esophageal sphincter (LES) and the diaphragm create a zone of high pressure 
between the low pressure esophagus and the low pressure stomach. The LES is a high pressure, 
3-4 cm segment of tonically contracted smooth muscle at the distal end of the esophagus. The 
crural diaphragm surrounds the LES and contributes to the high pressure of the LES. Both the 
LES and the crural diaphragm contribute to the physiologic function of the gastroesophageal 
junction. Resting LES pressure ranges from 10-30 mm Hg however, can reach > 80 mm Hg with 
enteric migrating motor complexes. LES pressure is affected by myogenic factors, intra-
abdominal pressure, gastric distention, peptides, hormones, various foods and many 
medications.
35  
 
The LES opens in both an antegrade and a retrograde manner. Movement of an ingested 
food bolus across the esophagogastric junction is facilitated by LES relaxation. The LES relaxes 
to similar pressures of the stomach and esophagus within 1 second of swallowing. Thus, when 
the food reaches the LES, the LES is relaxed but closed. The pressure generated by the food 
bolus, with the aid of peristalsis, forces the LES to open and the bolus to move across the 
esophagogastric junction. After 5-7 seconds of relaxation, the LES recovers its initial pressure.
35 
  
As gastric contents reflux into the esophagus, GER, some volume may reach the pharynx 
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and oral cavity, EER. If the refluxed material is not swallowed, the contents can pool in the oral 
cavity. Saliva and refluxed material can be suctioned and analyzed for pH and pepsin. 
Alternatively, some of the reflux can enter the larynx and be aspirated below the vocal cords into 
the tracheobronchial tree and lungs. Figure 2 demonstrates the location of GER and EER, 
collection of secretions and measurement of pepsin as an indicator of reflux. This figure also 
illustrates aspiration of EER below the larynx and into the upper airways and measurement of 
pepsin in tracheal secretions as an indicator of aspiration.  
Figure 2  
Reflux into Oral Cavity, Pharynx and Larynx
38
 
 
 
 
Reflux in the extraesophageal regions of the oral cavity, pharynx and larynx can lead to 
aspiration of the gastric contents below the level of the true vocal cords. In mechanically 
ventilated patients, the endotracheal tube traverses the vocal cords and ends in the trachea. 
Aspirated material, gastric contents or saliva, can be suctioned from the endotracheal tube. The 
tracheal secretions can then be analyzed for pepsin to detect aspiration of gastric contents as 
Extraesophageal reflux 
of gastric contents into 
the oral cavity, Pepsin 
positive oral secretions 
Gastroesophageal reflux 
Pulmonary 
aspiration 
of gastric 
contents, 
pepsin 
positive 
tracheal 
secretions 
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described later in this chapter. Figure 3 demonstrates the positioning of the endotracheal tube and 
suction catheter placement for obtainment of tracheal secretions. 
Figure 3  
Endotracheal tube in the airway
39
 
 
 
Stomach 
The lateral wall of the esophagus joins the stomach at an acute angle.  As food moves 
into the stomach, gastric motility is induced within 5-10 minutes of eating and persists for the 
time that food remains in the stomach.
40
 Intermittent phasic contractions occur with antral 
contractions propelling the gastric contents distally only to be returned back to the proximal 
stomach producing a mixing and grinding action. Feeding is associated with shortening of gastric 
muscle length and alteration of the distal stomach configuration. Antropyloroduodenal activity is 
observed manometrically, pressure measurement, as either intermittent isolated pressures or as 
peristaltic pressure waves that move varying distances through the antrum, across the pylorus 
and into the duodenum.
41
 Furthermore, peristaltic activity is regulated by small intestine 
receptors. Nutrients in the small intestine trigger a neurohumoral feedback loop leading to a 
decrease in antral contractility and an increase in pyloric contraction with a reduced antegrade 
propagating pressure wave resulting in a decrease in transplyoric movement of nutrients. 
Suction catheter inserted 
into the endotracheal tube 
to obtain tracheal 
secretions to be analyzed 
for pepsin 
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Retrograde peristaltic activity in the proximal duodenum moves chyme back into the distal 
antrum delaying gastric emptying. Motor activity following a meal depends on the consistency 
and composition of the ingested meal. Antral contractions are more intense when eating solids 
than those induced by a homogenized meal.
40
  
In response to a meal, the stomach also initiates secretory activity in response to gastric 
wall stretch. The stomach secretes several secretory products including hydrochloric acid, 
histamine, gastrin, ghrelin, pepsinogen and mucus. The volume of gastric secretion is 
approximately 1500 ml/day. Emotional stimuli, such as pain, increase gastric secretion during 
the fasting state from a physiologic few ml/hr to as much as 50 ml/hr.
33
 Pepsinogen is secreted 
by the chief cells of the fundus and body of the stomach and is stored in apical granules until 
stimulation. Pepsinogen is inactive until autocatalytically activated to pepsin under acidic 
conditions. Pepsinogen has a N-terminal prosegment domain containing 44 amino acids. Under 
acidic conditions below a pH of 5, the prosegment is removed through hydrolysis. Removal of 
the prosegment domain leads to pepsin in its mature and active state.
42
 
Gastric emptying occurs faster with liquid intake than with a meal of digestible solids. 
Gastric emptying of liquids is volume dependent with approximately 50% of emptying occurring 
within 8-18 minutes following a liquid meal. The volume propagated to the duodenum is a 
constant fraction of the volume remaining in the stomach. Thus, a larger volume of liquid will 
empty faster than a smaller volume.
40
 Nutrient containing liquids are emptied more slowly in 
women,
43
 and lipid containing liquids are emptied more slowly in the elderly.
44
 In addition, 
liquids of high caloric density empty slower than lower density liquids. However, approximately 
200 kcal/hr are propelled to the duodenum regardless of primary nutrient, carbohydrate, protein 
or fat.
44
 Inhibition of liquid emptying is highest after acid, glucose or oleic acid contact with the 
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proximal duodenum. Hence, carbohydrates and amino acids are the prime regulators of gastric 
emptying.
40
 
During fasting the migrating motor complex (MMC) is observed with three phases in the 
stomach and duodenum over approximately 84-112 minutes. MMC phase I is a period of relative 
motor inactivity with small pressure waves lasting approximately 50% of the cycle length. 
Increasing frequency of irregular contractions occurs in MMC phase II. Although comprising the 
shortest duration, 5-10 minutes, phase III is characterized by frequent, higher pressure 
contractions. The contractions primarily originate in the stomach although approximately one 
fifth of the contractions start in the proximal duodenum.
 
The MMC contractile pattern allows for 
movement of undigested food residue and sloughed enterocytes from the stomach and proximal 
small intestine.
40
 
Duodenum 
After feeding, chyme that is emptied from the stomach and subsequently mixed with bile 
and pancreatic juice is propelled away from the stomach through the small intestine. Stretch and 
mucosal stimulation provide the stimulus for peristalsis. In the proximal duodenum, bile and 
pancreatic secretion add approximately 2000 ml of volume to the ingested volume.
33
 As 
mentioned previously, some phase III MMC contractions originate in the duodenum. These 
contractions propagate orally leading to retroperistalsis activity.
46
 Duodenogastric reflux of 
bicarbonate and immunoglobulin A may reconstitute the antral mucosa during fasting.
47
 
Duodenal motor contractions can also lead to chyme backflow into the stomach and can impact 
gastric emptying.
48
 
Anti-reflux Mechanisms 
GER is a normal physiologic process occurring several times a day in most people, 
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especially after large meals.
4
 GERD occurs when there is a failure of the normal anti-reflux 
mechanisms. Three mechanisms are involved in the esophageal protective anti-reflux 
mechanism: 1) anti-reflux barriers, 2) esophageal acid clearance and 3) tissue resistance.
4, 49
 
Anti-reflux Barriers 
The anti-reflux barrier is comprised of the intrinsic LES, the diaphragm crura, the intra-
abdominal location of the distal segment of the LES, the phrenoesophageal ligaments and the 
acute angle formed between the cardia of the stomach and the esophagus. The major component 
of the anti-reflux barrier is the LES. The diaphragm crura provides extrinsic contraction around 
the LES contributing to LES pressure during inspiration as well as augmenting pressure during 
periods of increased abdominal pressure. The ligaments anchor the diaphragmatic crura. Lastly, 
the acute angle creating a flap valve type effect and the intra-abdominal location of the distal 
segment of the LES both contribute to gastroesophageal junction competency.
 
Anatomical anti-
reflux barriers help prevent reflux even during increased intra-abdominal pressure events.
4, 49-50
 
Esophageal Acid Clearance 
Esophageal acid clearance provides the second level of defense against reflux esophageal 
damage. The amount and severity of mucosal damage is dependent on the time required for 
esophageal acid clearance. Two processes are involved in esophageal acid clearance, volume 
clearance of the reflux material and acid clearance which involves restoration of normal pH in 
the esophagus after acid exposure.
 
Esophageal peristalsis works to clear acid reflux material. 
Primary peristalsis is initiated by swallowing regardless of reflux. Swallowing occurs 
approximately once per minute in awake individuals. One or two primary peristaltic contractions 
can clear a 15 ml bolus from the esophagus.
4, 49
 Esophageal peristalsis clears reflux material in 
the upright and supine positions although it is inoperative during deep rapid eye movement 
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sleep.
4, 51
 
Secondary peristalsis which is initiated by esophageal distention during reflux is less 
effective in acid clearance with less significant protection than primary peristalsis. Failed 
peristaltic function leads to an increased severity of esophagitis. With peristaltic dysfunction 
some of the refluxed material is cleared from the esophagus. Gravity contributes to bolus 
clearance when reflux occurs in the upright position; however, during supine positioning, the 
mechanism is not operative unless the head of the bed is elevated.
 4, 32
  
The basicity of saliva ranges from a  pH of 6.4-7.8
4
 and contributes to the clearance of 
the acidic reflux.
49
 Saliva is capable of neutralizing small amounts of acid remaining in the 
esophagus after the refluxed bolus has been cleared by several peristaltic contractions. However, 
saliva is not effective in neutralizing large volumes of acid (> 5 ml).
4
 Spontaneous swallowing 
results in saliva production. Average saliva volume is 1000 ml per day.
33
 Acidic fluids in the 
esophagus increase salivation. Physiological or pathological alteration in salivation may 
contribute to the esophageal damage associated with GERD. For example, during sleep, 
decreased salivation has been demonstrated to prolong acid clearance times. The aqueous 
bicarbonate rich secretions of the esophageal submucosal glands contribute to the dilution and 
neutralization of residual acid from reflux. Acidic reflux stimulates secretion by the esophageal 
submucosal glands even when swallowing does not occur.
4
 
Tissue Resistance 
Despite anti-reflux barriers and esophageal acid clearance, individuals may experience 1-
2 hrs of esophageal acid contact time and not necessarily develop GERD. The final protection 
that prevents the development of GERD is tissue resistance. Tissue resistance is a combination of 
both structural and functional components of the esophagus. Structural resistance is provided by 
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the relatively tight junctions of the epithelium and the lipid-rich glucoconjugates in the 
intercellular space of the esophageal mucosa which resist ionic movement at the intercellular as 
well as cellular level.  The functional resistance includes buffering and removal of hydrogen ions 
by the esophageal epithelium. Neutralization of the acidic reflux occurs via a sodium/hydrogen 
ion transporter and a sodium dependent chloride/bicarbonate exchanger. These ion transporters 
restore intracellular pH to neutral after acid reflux occurs. Additionally, esophageal blood flow 
removes hydrogen ions and carbon dioxide to maintain normal tissue acid-base balance. Blood 
flow is increased to the esophagus during acidic reflux. Lastly, esophageal cell injury with 
exposure to acid reflux stimulates cell proliferation with thickening of the basal cell layer of the 
epithelium. Esophageal repair requires days to weeks.
4
 
Injury Secondary to Gastric Reflux 
Inflammatory Response 
Esophageal mucosal injury secondary to GER is characterized by endoscopic findings of 
mucosal breaks, strictures, columnar metaplasia (Barrett esophagus) and adenocarcinoma. An 
inflammatory response contributes to the development of GERD complications. 
Proinflammatory cytokines such as interleukin (IL)-1 , IL-6 and IL-8 are increased. In addition 
platelet activating factor (PAF) is produced and released from the esophageal mucosa. PAF 
enhances eosinophil adherence to vascular endothelial cells and activates immune and non-
immune cells. PAF is produced and released after acid exposure. One of the immune mediator 
types activated by PAF is the reactive oxygen species (ROS). Increased ROS levels lead to 
oxidative stress. ROS levels are elevated in GERD with a depletion of antioxidants. In turn, the 
inflammatory mediators affect the fibroblasts, muscles cells, endothelial cells and immune cells 
in the esophagus leading to a chronic inflammatory condition. Gram-negative strains in the 
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esophageal microbiome are associated with GERD and Barrett esophagus. The inflammatory 
state as a result of GER results in reduced esophageal muscle contraction, increased esophageal 
fibrosis, dysplasia and carcinogenesis.
2
  
Pepsin Induced Injury 
Pepsin plays a major role in cell damage of the esophagus and extraesophageal structures 
during reflux. Pepsin is most active at an acidic pH of approximately 1.5-2.0 with declining 
activity as pH increases. However, the inactive enzyme remains stable at the higher pH and is 
reactivated when pH lowers again to a pH of approximately 3.0. Pepsin adhering to the 
epithelium can thus become reactivated during an acidic state. Also during reflux, pepsin 
adherent to epithelial cells can be subsequently endocytosed and cause internal cell 
derangements. Intracellular derangements occur from reactivation of pepsin within the cell.  
Derangements include changes in the Golgi system, the mitochondria and increased expression 
of genes associated with cell stress. Mitochondrial damage with repeated exposure to pepsin may 
lead to cell death.
3, 52
  
Factors Increasing Reflux 
Transient Lower Esophageal Sphincter Relaxations 
Transient LES relaxations (tLESRs) occur without swallowing or esophageal peristalsis 
and persist for longer periods (> 10 seconds) of relaxation than swallowing. The frequency of 
tLESRs associated with gastric acid reflux is increased in patients with GERD compared to 
healthy persons.
4, 49  
tLESRs occur most frequently in the postprandial state. Gastric distention is 
the major stimulus for tLESRs.
35, 49
 Additional factors that increase the rate of tLESRs include 
stress (coughing, straining) and subthreshold swallowing stimulation of the pharynx.
35 
Morbid 
obesity is also associated with an increased frequency of post-prandial tLESRs at a rate similar to 
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patients with GERD.
53 
Gastric Factors 
Gastric basal acid secretion rate, duodenogastric reflux and the rate of gastric emptying 
combine to determine gastric volume. The stomach secretes several secretory products including 
hydrochloric acid, histamine, gastrin, ghrelin, pepsinogen and mucus. The volume of gastric 
secretion is approximately 1500 ml per day. Emotional stimuli, such as pain, increase gastric 
secretion during the fasting state from a physiologic few ml/hr to as much as 50 ml/hr.
33
 The 
combination of acid and pepsin in GER disrupt the mucosal barrier of the esophagus leading to 
changes in the ion transporters, tissue changes and gross hemorrhage.
4
 Duodenogastric reflux can 
result in bile acid reflux. When combined with gastric acid and pepsin, bile acids from 
duodenogastric reflux cause further injury to the esophagus.
49, 54
 
Gastric emptying is the rate at which ingested food and secretions are emptied from the 
stomach. Gastroparesis is a chronic motility disorder of the stomach manifested as delayed 
gastric emptying without mechanical obstruction. Delayed gastric emptying is associated with 
GER in approximately 30% of patients with GERD diagnosis.
55
 Gastric stasis leads to proximal 
fundic distention which promotes tLESRs. Delayed gastric emptying is likely due to an impaired 
and disordered motor response throughout the stomach.
56
 With delayed gastric emptying, the 
increased volume in the stomach can result in gastric distention and subsequent reflux.  
Risk Factors for Gastroesophageal Reflux 
Several diseases and circumstances predispose patients to reflux and GERD. Pregnancy 
increases the risk of reflux due to the relaxing effects of circulating estrogen and progesterone on 
the LES. Patients with scleroderma develop smooth muscle fibrosis which lowers LES pressure 
and weakens esophageal peristalsis. Patients with Zollinger-Ellinson syndrome have increased 
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gastric volume due to hypersecretion of acid.
4
 Delay in gastric emptying has been demonstrated 
with several diseases and surgical conditions including hiatal hernia, liver cirrhosis, chronic 
pancreatitis, gastric cancer, gastric resection and cardiac or lung transplantation.
56
 
Reflux in Critically Ill Patients 
Critically ill mechanically ventilated patients with a nasally or orally inserted tube that 
transgresses the esophageal sphincters for decompression or feeding purposes are at increased 
risk for reflux. Reflux in this patient population may be infrequent or result in esophagitis. GER 
in the critically ill does not equate to GERD although patients with a history of GERD may 
demonstrate increased frequency and volume of reflux.  
Mechanism of Reflux 
Nind et al. studied 15 mechanically ventilated patients in the ICU. Patients underwent 
esophageal manometry, pH monitoring and intraluminal electrical impedance measurement. 
Patients were studied after a 4 hr fast and during a liquid gastric feed. An initial 100 ml nutrient 
bolus was administered through the central lumen of the manometric device followed by a 50 
milliliter (ml)/hr infusion for 5 hrs. Forty-six acid reflux episodes were measured. A decrease in 
esophageal pH to < 4 were detected 42 times in 11 patients and persisted for prolonged periods. 
The authors proposed impairment of volume and acid clearance as the cause of the downward 
pH drifts. Two patterns of esophageal motor events were associated with reflux: 1) absent basal 
LES pressure and 2) straining associated with coughing during suctioning. tLESRs were not 
observed in any patients. Basal LES pressure was uniformly low with a mean basal pressure of 
2.2 + 0.4 mm Hg. Swallowing was infrequent and no swallow-induced LES relaxation was 
observed. Esophageal body contractions were also infrequent and the majority of pressure waves 
were not propagated.  These findings demonstrate the mechanisms of GER during mechanical 
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ventilation in critically ill patients which are vastly different than the mechanisms discussed 
earlier.
57
  
In a recent pilot study, 10 of 50 (20%) gastric fed mechanically ventilated patients who 
were suctioned once had pepsin positive oral secretions via western blot analysis.
58  
Incidence of 
reflux over longer times, with various positions, and medical conditions requires further research. 
There is some literature which provides some evidence of conditions that increase reflux in the 
critically ill patient. These conditions are described in detail below.  
Gastric Tubes 
Gastric tubes are placed for decompression post-operatively and during mechanical 
ventilation to prevent gastric distention, reflux and aspiration. In the early 1960’s, the idea that 
acid may track toward the oral cavity along a nasogastric (NG) tube because the tube 
mechanically interferes with the LES barrier function was first proposed.
59
 Subsequently, large-
bore NG tubes were found to be associated with GER in mechanically ventilated patients at a 
significantly higher rate than patients without an NG tube.
60
 Three mechanisms have been 
identified that contribute to reflux and subsequent aspiration in patients with NG tubes: 1) loss of 
anatomic integrity of the UES and LES; 2) increased frequency of tLESRs; and 3) 
desensitization of the pharyngoglottal reflex.
61
  
Conflicting results regarding effect of NG tube size have been reported.  In normal 
volunteers, 8 Fr compared to 14 Fr NG tubes resulted in no difference in amount of reflux or 
reflux episodes.
62
 Also, no differences in GER and microaspiration were observed in intubated 
patients with large bore (6.0 mm) compared to small bore (2.85 mm) NG tubes.
63
 However, a 
small bore NG tube (2.66 mm diameter) in continuous gastric fed mechanically ventilated 
patients eliminated GER and aspiration.
64
 The size of the NG tube traversing the esophageal 
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sphincters may be important but needs further investigating.  
NG tubes for gastric drainage, sump tubes, are used to reduce gastric volume. A study 
conducted in cardiac surgery patients examined three groups: 1) no NG, 2) NG (14 French) to 
gravity, and 3) NG (14 French) to suction.
  
Esophageal and tracheal pH probes were placed to 
detect reflux and aspiration. The researchers found that in patients at low risk of GER (excluded 
patients with known GERD, diabetes, hiatal hernia and morbid obesity) reflux was very low in 
patients managed without an NG. The use of low, intermittent suction also resulted in an 
infrequent rate of reflux. However, reflux was increased when the NG tube was drained by 
gravity. One patient in the NG gravity group had a tracheal pH indicative of aspiration.
65
 Similar 
results were found with patients undergoing elective bowel surgery. Seven patients had NG tube 
placement intraoperatively and for 24 hrs postoperatively while 8 were randomized to no NG 
tube. All patients had continuous manometry, pressure measurement recording, and esophageal 
pH monitoring. Patients managed with an NG tube had significantly more reflux episodes (137 ± 
71.1 compared to 7.8 ± 3.5) and a longer duration of reflux. Additionally, the mean LES 
pressures were lower in the NG group (6.4 ± 4.2 vs. 20.6 ± 12.8).  However, this difference was 
not statistically significant.
66
 Size of NG tube was not reported.  
Percutaneous endoscopic gastric (PEG) tubes are frequently placed to reduce GER 
associated with NG tubes. LES pressures are maintained at normal levels in patients with a PEG 
until rapid intragastric bolus instillation which was found to reduce LES pressure and led to 
GER.
67
 Patients with neurologic dysphagia with a PEG tube may be at higher risk for GER than 
patients who require a PEG tube for mechanical reasons. Additionally, at the time of PEG tube 
placement, observations of a more severe reflux esophagitis grade was associated with higher 
GER after PEG tube placement.
68
 In both non-ventilated and ventilated patients, PEG tubes have 
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been found to reduce GER compared to NG tubes but not completely prevent it.
69-72 
Therefore, 
while PEG tubes might reduce the frequency of GER in critically ill patients they do not 
completely eliminate reflux. 
Gastric Motility 
Gastric motility and gastric emptying are altered during critical illness. Gastric emptying 
is delayed in up to 50% of critically ill patients. During intragastric nutrient bolus, fewer 
antegrade and more retrograde waves were reported in the gastric antrum and duodenum in 
critically ill patients and the waves were shorter in length. With duodenal feeding infusion, 
critically ill patients demonstrated longer and more frequent mixed duodenal propagated waves, 
a reduced percentage of antegrade antroduodenal waves and an increased percentage of mixed 
antroduodenal waves.
39
 The functional association between the proximal and distal gastric 
regions is abnormal and may further contribute to delayed gastric emptying during critical 
illness.
73
 These alterations combine to slow gastric emptying during gastric or duodenal feeding. 
This motor pattern of antral hypomotility, reduced propagated waves and increased retrograde 
propagation is similar to the stress response seen in healthy volunteers.
39
  
Delayed gastric emptying has also been shown in animal models with induced acute 
stress while prolonged stress led to adaptation and return to normal gastric contractions and 
gastric emptying.
74-75
 Decreased gastric emptying and decreased gastrointestinal motility has 
been identified in various models with endotoxin administration and sepsis.
76
 The effects of 
stress on gastric emptying in the critically ill patient remains to be elucidated. However, several 
factors such as physical stress, as observed with abdominal surgery or sepsis, have been shown 
to result in decreased ghrelin levels with potential for decreased gastric emptying.
77
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Duodenogastric Reflux and Esophageal Damage 
Intragastric bile concentration in 26 critically ill mechanically ventilated patients was 
significantly higher than healthy controls indicating duodenogastric reflux.
78
 These findings were 
supported by a study of mechanically ventilated critically ill patients who received a radioactive 
traced jejunal liquid diet.  Duodenogastric reflux was documented in 10 of the 11 patients with a 
significant increase in radioactivity of the gastric contents and an increase in bile acid 
concentration from 392 μmol during fasting to 1446 μmol in the fed state.
79
 In critically ill 
mechanically ventilated patients, duodenogastroesophageal reflux led to an increased severity of 
esophagitis as the volume of gastric aspirate increased. 
 
Furthermore, erosive esophagitis with 
bile reflux was reported in 48% of a sample of 26 critically ill patients after less than one week 
of mechanical ventilation despite acid-suppressive therapy. Esophagitis was attributed to 
mechanical irritation of the nasogastric tube and chemical injury from acid and bile during 
duodenogastroesophageal reflux.
80
 Thus, while duodenogastric reflux is physiologic, 
mechanically ventilated patients may have an increase in GER secondary to an increase in 
duodenogastric reflux which leads to erosive esophagitis. 
Pulmonary Aspiration of Gastric Contents 
Farrell et al. attributed the first description of GER and respiratory disease to Sir William 
Osler in 1892.
81
 Aspiration involves inhalation of material (oral or gastric) into the airway below 
the level of the true vocal cords. Microaspiration refers to the aspiration of a small volume of 
material that is generally not detected clinically. Macroaspiration involves aspiration of a large 
volume of material that is often detected clinically. Large-volume aspirations following vomiting 
are infrequently witnessed by clinicians.
29
 However, microaspirations occur frequently and are 
clinically undetected.
14
 Aspiration could involve repeated episodes of microaspiration yet not 
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result in acute symptoms.
82
 Pulmonary pathology after aspiration varies widely. Variables 
impacting pathology include quantity and nature of aspirated material (blood, bacteria, 
gastric/oral secretions, liquids or food particles), chronicity of aspiration and the individual’s 
host defense mechanisms.
82-83
  
Aspiration pneumonia is defined as “a parenchymal inflammatory reaction to aspirated 
material mediated by an infectious agent, characterized by an infiltrate on chest x-ray.”
1
 The 
infectious process of aspiration pneumonia is most frequently a result of aspiration of 
oropharyngeal or gastric secretions colonized by bacteria. Aspiration pneumonitis entails a non-
infectious acute inflammatory response to the aspirated material that also demonstrates an 
infiltrate on chest x-ray. Aspiration pneumonitis is a chemical pneumonitis associated with 
aspiration of gastric contents. Additional conditions related to aspiration include bronchiolitis, 
airway obstruction, lung abscess, acute lung injury and acute respiratory distress syndrome.
83-83
   
Risk Factors for Aspiration 
Critically ill patients often have a decreased level of consciousness which impairs the gag 
reflex and leads to pooling of oral secretions in the posterior oropharynx. In patients with an 
endotracheal tube, a direct pathway is available for these secretions to enter the lungs.
16
 The cuff 
of an endotracheal tube may also result in dysfunction of the UES.
63 
Subthreshold swallowing 
stimulation of the pharynx is reported to increase tLESRs.
35
 The presence of an endotracheal 
tube may provide sufficient stimulation of the pharynx to increase tLESRs although no tLESRs 
were observed by Nind et al. in patients with endotracheal tubes.
57
  Alterations in both UES and 
LES function secondary to endotracheal tubes may increase reflux and lead to aspiration. 
 Aspiration of gastric contents is a complication associated with general anesthesia, 
occurring in one of every 2000-3000 general anesthetic procedures.
82-83
 The risk of anesthesia 
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associated aspiration is lowest in healthy patients with no known risk factors for aspiration.
83 
Aspiration occurs more frequently in patients requiring emergent intubation of the airway which 
most commonly occurs in the field or in the emergency department after trauma. Aspiration also 
occurs frequently in acutely decompensating patients in the emergency department and inpatient 
settings during emergent intubation.
82
 
Other risk factors include decreased level of consciousness secondary to sedation, alcohol 
intoxication or neurologic disease process and neuromuscular diseases. Risk factors for GER 
discussed previously increase the possibility for aspiration. Although risk factors for aspiration 
have been identified, Raghavendran et al. stated that “the true incidence of aspiration –induced 
lung injury is difficult to establish considering that most aspiration events are silent or 
unwitnessed.”
82
  
Airway and Lung Injury Associated with Aspiration 
Gastric content has been shown to cause hyperpermeability of airway epithelium as a 
result of acid, pepsin activity and low osmolarity.
84
 Pepsin is associated with mucosal 
inflammation of the esophagus and extraesophageal structures.
85
 A study conducted to determine 
the effects of pepsin at a higher pH on epithelial cells of the pharynx demonstrated 
microscopically that the mitochondria and Golgi system were damaged. Conversely, the authors 
found no damage in the control cells, cells with no pepsin exposure. Additionally, pepsin altered 
the expression of multiple genes connected to stress and toxicity.
86
  
Gastric acid and pepsin also damage lung cells and stimulate inflammatory factors 
through ROS,
87
 increased susceptibility to bacterial load,
88
 and alveolar macrophage 
inflammatory response.
89
 Several local and systemic inflammatory mediators are reported to 
increase secondary to aspiration of gastric contents including tumor necrosis factor-  and IL-8.
82
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In a rat model, intratracheal instillation of dilute hydrochloric acid resulted in an acute 
neutrophilic inflammatory response at 4-6 hrs after instillation leading to a loss of pulmonary 
microvascular integrity and extravasation of fluid and protein into the airways and alveoli.
82
  
Unique inflammatory mediator profiles found in mice and rat bronchoalveolar lavage specimens 
in response to various types of aspiration (normal saline, hydrochloric acid, small non-acidified 
gastric particles or acid and gastric particles) were used in a statistical model to predict the 
various aspiration forms and demonstrated the inflammatory insult seen in aspiration.
90-91
 Similar 
to acid instillation, neutrophilic inflammation occurs at 4-6 hrs but no edema was observed with 
food particle induced lung injury.
82
 In a rabbit model, human gastric secretions were highly 
proinflammatory and caused dysfunction of the alveolar capillary barrier leading to lung 
edema.
92
 These changes were not pH dependent. Therefore, medications to alkalinize the gastric 
secretions would not eliminate damage to the lungs. 
Further evidence of lung damage secondary to gastric aspiration was found in neonates. 
The neonates who had tracheal aspirates with higher concentrations of pepsin had a higher 
incidence of bronchopulmonary dysplasia.
93
 Evidence of gastric aspiration in patients with lung 
allografts who reported GER demonstrated positive pepsin levels in bronchoalveolar lavage 
secretions and the detection of pepsin was associated with mild to moderate organ rejection.
94
 
Pepsin was not detected in control volunteer patients. These findings were subsequently 
validated in a study of lung transplant patients compared to control subjects. The authors 
concluded that gastric aspiration may play a role in the development of lung allograft rejection.
 95
 
Additional Risk Factors for Reflux and Aspiration in ICU Patients 
Several risk factors have been identified that lead to GER, aspiration pneumonia and 
pneumonitis. Previously discussed factors include gastric distention, obesity, stress related to 
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coughing or sneezing and tubes traversing the UES and LES. The elevation of the HOB to less 
than 30
o
, vomiting, gastric feeding and decreased level of consciousness have been identified as 
significant risk factors for aspiration and pneumonia.
14
 Presence of a tracheostomy, nasogastric 
feeding, histamine (H2) blockers and decreased level of consciousness were significant risk 
factors in a study by Carrilho et al.
11
 Metheny et al., found that maintaining HOB elevation 
greater than 30
◦
 and use of a distal small bowel feeding tube significantly reduced aspiration and 
aspiration pneumonia.
96
 Another study demonstrated that emergent intubation in the pre-hospital 
setting compared to more controlled intubation in the emergency room was associated with a 
higher incidence of aspiration measured by a qualitative pepsin plate assay based on fibrinogen 
digestion.
9
  
Lastly, several medications commonly administered to ICU patients increase reflux and 
aspiration risk. Opioid analgesics, nitrates, calcium channel blockers and theophylline relax 
smooth muscle and are reported to decrease LES pressure which can lead to reflux.
35
 Opioid 
analgesics also delay gastric emptying. In addition, anticholinergic agents such as 
prochlorperazine, promethazine and scopolamine, delay gastric emptying due to inhibition of 
acetylcholine receptors of cholinergic neurons that supply the stomach via the vagus nerve.
40
 
Other medications administered to ICU patients with reported delay in gastric emptying include 
proton pump inhibitors, H2 receptor antagonists, sucralfate, and diphenhydramine.
56
 
Interventions to Reduce Reflux and Aspiration 
Head of Bed Positioning 
Positioning of patients is identified as one of the most important nursing interventions to 
decrease GER, aspiration and VAP.
  
In the supine flat position, the esophagus is positioned 
horizontally while in the semi-recumbent position the esophagus is oriented above horizontal. 
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Therefore, during semi-recumbent positioning, reflux of gastric contents is counterbalanced by 
gravity.
32
 Figure 4 is an illustration which demonstrates esophageal alignment in the semi-
recumbent position compared to the supine position. The top panel (a) demonstrates esophageal 
alignment above the horizontal position in the semi-recumbent position. The bottom panel (b) 
illustrates esophageal alignment below horizontal in the flat, supine position. In the semi-
recumbent position, esophageal alignment above horizontal hinders the reflux of gastric contents. 
Figure 4  
Esophageal Orientation in the Semi-recumbent Compared to Supine Position
32 
 
 
Permission to use figure was granted by Lippincott Williams & Wilkins. Promotional and 
commercial use of the material in print, digital or mobile- device format is prohibited without the 
permission from the publisher Lippincott Williams & Wilkins. 
To reduce the risk of aspiration, guidelines from many organizations recommend that the 
HOB of ventilated patients be maintained at 30-45
◦
. These organizations include the CDC,
21
 
AACN,
22
 ASPEN,
1
 Canadian Critical Care Trials Group,
23
 and SCCM.
24
 HOB positioning 
recommendations found in the above cited guidelines are based on several studies. In a 
randomized trial of 19 ventilated patients using radioactive labeling of gastric contents, mean 
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radioactive counts of endobronchial secretions were higher in patients in the supine position 
compared to patients positioned at 45
◦
 and aspiration pattern was time dependent.
97
 Supine 
positioning in the first 24 hrs of mechanical ventilation was associated with an increased risk of 
VAP in a cohort study of 277 ventilated patients.
98
 In a subsequent randomized trial in 86 
ventilated patients, patients in the semi-recumbent group (45
◦
) had a lower rate of clinically 
suspected nosocomial pneumonia than patients in the supine position. Healthcare providers were 
instructed not to change the position except for medical requirements. However, correctness of 
position was only checked daily and method for measuring HOB elevation was not reported.
 99
 
A randomized feasibility study of semi-recumbent (45
◦
) positioned patients compared to 
supine positioned patients demonstrated that the target position of 45
◦
 was not achieved for 85% 
of the 6-7 day study period with no significant difference in VAP rates. HOB elevation was 
measured every 60 seconds with a transducer and stored in a computer. Patient preferences for 
positioning for comfort were respected.
100
 A randomized control trial comparing HOB elevations 
of 45
◦
 versus 25
◦
 on VAP rates in 30 patients was underpowered to detect a difference in VAP 
rates. Protractors were used to measure HOB elevation but no discussion on frequency of 
measurements or compliance with assigned group was provided.
101
 Finally, a meta-analysis of 
randomized controlled trials on HOB positioning on incidence of VAP concluded that HOB 
elevation of 15-30
◦
 was not sufficient to prevent VAP and that patients positioned to 45
◦
 had a 
lower incidence of VAP compared to supine patients.
102
 
Despite guideline recommendations for HOB elevation, several studies have 
demonstrated that patients are often maintained at less than 30
◦
 HOB elevation.
18, 20, 100, 103-104 
Hemodynamic instability and procedures are cited as reasons for HOB positioning less than 30
◦
. 
Rose et al. identified the need for research to confirm the superiority of 45
◦
 semi-recumbent 
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positioning for VAP reduction before more quality initiatives to improve compliance with 45
◦
 
HOB elevation are developed since maintenance at this HOB elevation may not be clinically 
feasible.
104
  
Similar findings were reported with the implementation of a comprehensive 45
◦
 HOB 
elevation program that included education of nurses and physicians and standardized orders. 
Although HOB angle increased with implementation, less than one-third of patients were 
observed at 45
◦
 elevation. Helman et al. also surveyed nurses regarding barriers to 45
◦
 HOB 
elevation positioning.  Fifty-seven nurses were surveyed and cited the following concerns with 
the 45
◦
 positioning: 1) increased probability of patient sliding down in bed (100%), 2) increased 
difficulty with turning on a rotation bed (77%), 3) patient’s discomfort and sleep disruption 
(35%), 4) concern over increased skin breakdown (22%), and 5) affect on hemodynamic 
monitoring (13%).
105
 Other reasons for lowering the HOB can be found on the practice alert 
document by AACN related to the prevention of VAP. Reasons cited include cardiovascular and 
neurological alterations, and processes of care.
22
  
On occasion, patients’ beds are placed in a head down position resulting in the head being 
lower than the feet. This position is termed trendelenburg. A bariatric repositioning algorithm 
describes the use of trendelenburg position when pulling the patient up in bed to facilitate 
movement.
106
 Also, bedside procedures such as central venous cannulation and central venous 
catheter removal are performed in the trendelenburg position to enhance jugular vein cannulation 
and reduce the risk of air embolism. No studies have examined the impact of trendelenburg 
position for procedures or repositioning on GER or aspiration.  
With the implementation of an aspiration risk-reduction protocol, Metheny et al. were 
able to achieve mean HOB elevations of 30
◦
 in 90% of patients. Investigators were present 16 
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hrs/day, 7 days/week which likely influenced the high compliance.
96
 Interruptions in HOB 
elevation and trendelenburg impact on reflux and aspiration need further study.  
Gastric Residual Volume Monitoring 
Delayed gastric emptying is an important factor associated with GER and subsequent 
aspiration of gastric contents especially in gastric fed supine patients. Gastric residual volumes 
(GRV) are measured by critical care nurses every 4 to 6 hrs to assess for gastric emptying and 
feeding tolerance. Syringe aspiration of the gastric tube is the primary method used by nurses to 
measure GRV. Patient position, tube material, location and number of aspiration ports, tube 
location in the stomach and syringe gauge will all impact the ability to obtain an accurate 
GRV.
107-109 
Patients with higher GRV during gastric feeding display delayed gastric emptying.
110
  
GRV is higher in the first few days of tube feeding.
111-112
 The use of GRV to detect feeding 
intolerance and its association with aspiration or VAP has been debated.
113-117
 The differences 
observed in feeding intolerance and pneumonia rates may be related to different detection 
techniques used to identify aspiration of gastric contents and diagnose pneumonia. Furthermore, 
different GRVs were examined in various studies. Although no consistent relationship between 
GRV and aspiration pneumonia was found, a gastric residual volume greater than 250 ml was 
associated with a higher rate of aspiration pneumonia in mechanically ventilated gastric fed 
patients.
115
 GRV trends of increasing volumes can be a marker of intolerance and provide a 
reasonable indicator for impaired gastric emptying. Gastric residual volumes between 250-500 
ml should alert the nurse to the patient’s increased risk for reflux and consideration of 
interventions such as prokinetic agents or placement of the feeding tube beyond the second 
portion of the duodenum.
96
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Other methods used to measure gastric emptying include refractometry,
109 
acetaminophen 
absorption,
111, 118
 scintigraphy,
119-120  
electric impedance tomography,
119
 breath tests
120-122 
and 
ultrasound.
123
 However, these methods are generally not available to most bedside critical care 
clinicians. Recent studies have examined the clinical utility of ultrasonographic measurement of 
the antral cross section area in the preoperative setting as a measure of gastric volume.
124-125 
Ultrasonography holds potential as a clinical measure of gastric volume and gastric emptying. 
The future role of ICU bedside ultrasonography and the other previously mentioned methods is 
uncertain. However, new methods may provide better evaluation of gastric emptying in patients 
at high risk for reflux than GRV syringe aspiration measurements. 
Gastric or Small Bowel Tube Location  
A meta-analysis of the prophylactic use of an NG tube for gastric decompression in 
surgical patients examined 37 studies. Patients in these studies were placed into two groups. 
Group one included all patients who did not have a NG tube placed in the peri-operative period, 
NG tube was removed in the operating room or post-anesthesia care unit or within the first 24 hrs 
post-operatively. Patients in group two had a NG tube maintained until return of bowel function, 
generally indicated by spontaneous passage of flatus. Several outcomes were examined including 
postoperative pulmonary complications. Twenty-seven of the studies examined pulmonary 
complication of pneumonia or atelectasis. Non-routine use of NG decompression provided some 
benefit although it was not statistically significant (p = .09, OR = 1.45, CI = 1.10-1.92).
126
 
The incidence of VAP was studied in patients receiving duodenal or jejunal feeding with 
a smaller bore tube. The use of small bowel compared to gastric feedings did not result in 
reduced VAP rates.
127-129
 Feeding tube placement was reported in the second portion of the 
duodenum or beyond in one study
127
 and post-pyloric in one study.
128
 In the third study, a dual 
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lumen nasojejunal tube was used with four different placement techniques, including blind 
technique. Exact location was not described.
129
 In a study of 33 patients randomized to either 
gastric or post-pyloric feeding tube, GER and microaspiration were both reduced in patients fed 
post-pyloric. These authors also found that 92% of post-pyloric fed patients had episodes of 
duodenogastric reflux. Post-pyloric feeding tube location was within the first portion of 
duodenum in 8 patients, the second portion in 3 patients and the fourth portion in 1 patient.
130
 
Jejunal feeding compared to gastric feeding was compared in 38 critically ill patients. No 
pneumonia was observed in the 19 jejunal fed patients while 2 of the 19 gastric fed patients were 
diagnosed with pneumonia.
131
  Additionally, pneumonia occurred less often when feeding tubes 
were placed in the second portion of the duodenum or beyond in mechanically ventilated tube 
fed patients
132-133 
with pneumonia rates lowest when tubes were placed in the fourth portion of 
the duodenum or beyond.
133
 Therefore, small intestine location in the distal duodenum or 
jejunum may be the significant factor in reducing reflux.  
For long term feeding, the use of distal duodenal or jejunal feeding in addition to gastric 
decompression may reduce reflux and aspiration.
134 
Feeding into the small bowel while 
maintaining gastric decompression with a gastric tube may provide a feasible method to reduce 
GER and aspiration in the critically ill mechanically ventilated patients.
135
 However, this requires 
further research since 2 tubes, a feeding and a decompression tube, would be traversing the LES.  
Feeding Method 
Patients who do not tolerate bolus gastric feeds may benefit from continuous feeds.
7
 
However, one study of 106 mechanically ventilated patients demonstrated that intermittent 
feeding compared to continuous feeding resulted in lower risk of aspiration pneumonia.
136
 Other 
studies have found no difference in feeding method in critically ill or healthy volunteers on 
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pneumonia or GER respectively.
137-138 
More research is needed comparing intermittent bolus and 
continuous feeding.    
Recently, several studies have reported the impact of thickening agents added to liquid 
meals.
139-142
 In healthy volunteers, addition of pectin to enteral solution resulted in accelerated 
gastric emptying.
139
 Liquid nutrients prepared with agarose, a gel, and administered via a PEG 
tube in a geriatric population resulted in decreased reflux without tube clogging in patients with 
established PEG tubes.
140
 A similar study found that the addition of agar to the enteral solution 
and administered via a PEG tube in patients with a known history of aspiration reduced GER but 
did not eliminate it in all patients.
141
 However, another study using half-solidification of liquid 
nutrients showed no reduction in GER with PEG tube administration.
142
 Research is needed to 
examine the impact of thickening gastric tube feeding in a mechanically ventilated population on 
reflux and aspiration. 
Prokinetics  
Prokinetics are agents that increase gastrointestinal motility. Prokinetics are widely used 
to promote tolerance to gastric enteral nutrition in the setting of delayed gastric emptying.
143
 
Several studies have examined metoclopramide and erythromycin on gastric emptying and GRV 
in the critical care population. Metoclopramide acts primarily as a dopamine (D2 receptor) 
antagonist, 5-hydroxytryptamine (5-HT)3 antagonist and 5-HT4 agonist with efferent myenteric 
cholinergic neurons releasing acetylcholine.
144 
Activation of these receptors triggers an intense 
burst of gastric contractions and accelerates gastric contractions.
48
 Erythromycin is a macrolide 
antibiotic which also acts as a motilin receptor agonist.
144
 Motilin is synthesized from endocrine 
cells of the duodenojejunal mucosa.
145
 Motilin receptors are primarily found in smooth muscle 
cells of the gastric antrum, duodenum and colon but their density is highest in the gastroduodenal 
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region.
146
 Erythromycin stimulates high-amplitude antral contractions which are rapidly 
transmitted across the pylorus to the duodenum.
144 
Erythromycin improves coordination of 
antroduodenal motility in a dose dependent fashion. The dosage required to accelerate gastric 
emptying is less than the dose required for antibacterial activity.
48
 Moderate doses of 200 mg are 
frequently given; however, lower doses of 70 mg may be equally effective.
147 
 
Studies of erythromycin have demonstrated an improvement in gastric emptying with the 
greatest impact on patients with delayed gastric emptying
147 
and in the first few days of 
therapy.
148
 In two studies, both erythromycin and metoclopramide were found to reduce GRV in 
critically ill patients receiving gastric feedings. However, erythromycin led to lower GRV
118, 148 
and improved the proportion of patients who achieved successful feeding.
148
 Combination 
therapy with both erythromycin and metoclopramide was found to be even more effective than 
erythromycin alone.
149
 Of concern with erythromycin is the possibility of antibiotic resistance 
with frequent use and diminished effectiveness after several days.
48
 
Ghrelin receptors are the most recent focus of prokinetic agents. Ghrelin is structurally 
similar to motilin and both motilin and ghrelin are now classified as members of a new motilin-
ghrelin peptide family.
145, 150
 Secreted by the enteroendocrine cells of the oxyntic mucosa of the 
gastric fundus, ghrelin is the endogenous ligand for the growth-hormone secretagogue receptor 
and is known to have many endocrine activities. Ghrelin receptors are expressed throughout the 
gastrointestinal tract, but similar to motilin receptors, their density is highest in the stomach and 
duodenum with minimal colonic activity in humans.
151
 Most often identified with appetite 
stimulation, ghrelin also has prokinetic activity.
150
 In healthy volunteers, ghrelin induced phase II 
like contractions of the stomach.
143, 150
 Ghrelin is reported to stimulate the MMC, increase gastric 
motility and promote gastric emptying.
151
  Long term use of ghrelin for gastric motility may not 
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be warranted because of its various actions. However, ghrelin may be useful in acute episodes of 
decreased gastric emptying.
152
 Synthetic non-peptide ghrelin receptor agonists have been 
developed to stimulate gastric emptying without the full complement of ghrelin receptor activity 
and are currently being studied in healthy volunteers, diabetics and post-operative patients.
151
 
Ghrelin blood concentrations are reduced in critical illness, with observed levels of acyl ghrelin 
lowest in patients intolerant to gastric feeds. However, no research of ghrelin agonists and gastric 
emptying in ICU patients exists.
48, 152
 
Subglottic Secretion Drainage 
The use of subglottic secretion drainage (SSD) in intubated patients has been studied 
since 1992. Theoretically, removal of subglottic secretions will reduce microaspiration and the 
risk of VAP. SSD requires an endotracheal tube with a separate dorsal lumen directly above the 
endotracheal tube cuff allowing for removal of secretions. Dezfulian et al. conducted a meta-
analysis of the use of SSD to prevent VAP. The authors concluded that SSD is effective in 
preventing early-onset VAP in patients expected to require intubation and mechanical ventilation 
for > 72 hrs.
153
 A more recent meta-analysis was published by Leasure and colleagues. In an 
analysis of ten studies, the authors found a 52% reduction in VAP with SSD (risk ratio 0.52, 95% 
CI = 0.43-0.64).
154
 Authors of the second meta-analysis arrived at similar conclusions as 
Dezfulian et al. regarding the benefit of SSD to prevent VAP.  
Measures to Detect Reflux and Aspiration 
Esophageal pH Monitoring for Reflux 
Ambulatory intraesophageal pH monitoring is the standard for establishing pathological 
reflux. A pH probe is passed nasally and positioned 5 cm above the LES as determined under 
esophageal manometry studies. The probe is connected to a data device capable of collecting pH 
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values every 4-6 seconds. The patient can record events such as symptoms, meals and position 
changes over the 18-24 hr data collection period.
4
 Placement of pH probes in the esophagus of 
surgical and critically ill patients have also been used to study reflux in critical care  
patients.
65, 80, 155
 The probes are not placed by manometric identification of the LES but rather, 
confirmation of esophageal location is based on obtainment of acidic pH to determine gastric 
location. The probe is then withdrawn into the lower esophagus until a pH change is noted. To 
detect aspiration, pH probes can also be placed in the trachea. Russell et al. placed pH probes in 
the esophagus and trachea to detect reflux and aspiration in cardiac surgery patients.
65
 
Methods to Detect Aspiration 
Detection of aspiration has been studied by different measurement techniques and 
diagnostic tests over the past twenty years. Diagnostic tests include chest radiograph and high 
resolution chest computed tomography. Both tests lack sensitivity to lung aspiration as the cause 
of lung injury.
6
 Meal labeling with radioactive markers is considered sensitive and specific for 
measurement of gastric emptying although it lacks utility for bedside use due to costs and 
resources
156
 and has variable sensitivity for aspiration.
6
  
The addition of blue dye to tube feedings and assessment of suctioned secretions for blue 
discoloration was routinely performed in the 1980’s but has since been deemed unreliable and 
even unsafe for patients.
157, 158
 Glucose oxidase testing has also been disproved as a reliable 
measure of lung aspiration
158
 because glucose presence in tracheal secretions is impacted by 
blood glucose levels.
159
 Lipid-laden alveolar macrophages in bronchial alveolar lavage samples 
has yielded conflicting results with excellent sensitivity but low specificity for aspiration.
6,81
 
Pepsin Assay  
Pepsinogen is synthesized in the exocrine chief cells of the stomach. Pepsinogen 
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secretion occurs in response to food ingestion. Pepsionogens are inactive proenzymes that are 
converted in an acid environment to the active form pepsin. Pepsin initiates protein digestion. 
Pepsin is an ideal marker for reflux and aspiration for several reasons: 1) pepsin is not normally 
found in the pharynx, tracheobronchial tree or lungs, 2) pepsin remains biologically active and 
detectable after reflux and aspiration, and 3) pepsin can be retrieved with minimally invasive 
procedures.
81
 Pepsin was first utilized in a study by Badellino and colleagues using a hemoglobin 
digestion method. In a study of rabbits with instilled gastric juice, the authors described 100% 
sensitivity but specificity was not reported.
160
 However, a major limitation is that the hemoglobin 
digestion method can not be used to detect pepsin that has been degraded in the alkaline 
environment of the lung.
81
  
Ufberg et al. examined a pepsin-specific qualitative enzyme plate assay using the 
digestion of fibrinogen in an acidified agarose gel. Gastric aspirates from NG tubes and tracheal 
aspirates from an endotracheal tube were obtained upon tube placements in 20 patients 
undergoing elective surgery. All tracheal aspirates were negative and all gastric aspirates tested 
positive.
161
  
Immunoassays detect or quantitatively measure a specific protein in blood or body fluids. 
Immunoassay techniques utilize an antibody-antigen relationship to identify a specific protein 
such as pepsin. The most common immunoassay methods used are western blotting and enzyme-
linked immunosorbent assay (ELISA). Western blotting uses protein immunoblotting to identify 
a protein based on its isoelectric point, electrical charge, molecular weight, molecular structure 
or a combination of these factors. With the ELISA technique, the antigen is fixed to a platform 
and the antibody linked to an enzyme, specific to the protein of interest, is washed over the plate 
which allows for binding.
162
 Metheny et al. developed a western blot immunoassay of rooster 
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polyclonal antibodies to pepsin which has subsequently been used to study aspiration in pediatric 
and adult patients. The technique detects pepsin concentration as low as 1 microgram/mL
163
 with 
a sensitivity of 93% and a specificity of 100%.
164
 Using the western blot immunoassay to detect 
pepsin in tracheal secretions of adult patients receiving enteral nutrition, the researchers found 
that patients with frequent aspiration were 4 times more likely to develop pneumonia than were 
infrequent aspirators.
14
  
Another pepsin assay involves the use of a proteolytic enzyme assay with fluorescein 
isothiocyanate-labeled casein. This technique was reported to detect pepsin at a level of 12.5 
ng/50 μL. The fluorescein technique was used in a pediatric patient population undergoing 
general anesthesia. The researchers compared children with clinically significant GER to 
children with no known history of reflux. Pepsin was detected in 26% of children with known 
reflux, 88% of children with reflux and chronic respiratory symptoms and 84% of children with 
known reflux and chronic respiratory symptoms. None of the 26 children without a history of 
GER had tracheal pepsin. Specificity was not reported with this technique.
165
  
 Using an enzymatic assay with a fluorescent substrate, tracheal aspirates from premature 
mechanically ventilated neonates were analyzed for pepsin.  Tracheal aspirates were obtained 3 
hrs after a feeding on 7 different days over a 28 day period from 59 neonates. Pepsin was 
detected in 222 of 239 tracheal aspirates.
93 
In a similar study, an active enzyme assay was used to 
identify pepsin in tracheal aspirates from 27 mechanically ventilated children. Seventy percent of 
the children had pepsin positive tracheal aspirates. Pepsin positive secretions were found more 
often in children with uncuffed tracheal tubes, as opposed to those with cuffed tubes.
11
 Other 
investigators have reported that pepsin positive bronchoalveolar lavage fluid in lung allograft 
patients was evidence of aspiration.
94 
In another study, the presence of pepsin and pepsinogen 
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was measured in the saliva of healthy volunteers by a new technique using immunoaffinity-mass 
spectrometric assays. The final assay results were reported to have <15% error.
166
 
Immunoaffinity-mass spectrometric assays have not been tested in patients with known reflux or 
in critically ill patients.  
Investigators have used these various measures to measure pepsin as a marker for GER 
and aspiration. To examine the use of a pepsin assay to detect reflux, Potluri et al. studied a 
group of 16 patients with GERD symptoms. The patients underwent simultaneous 24 hr 
esophageal pH monitoring and collection of saliva and sputum samples for pepsin measurement 
using a fibrinogen digestion pepsin assay.  Of the secretions collected, 161 were negative for 
pepsin and 19 were positive. Esophageal reflux was not detected via pH monitoring in patients 
who had negative pepsin assays. In contrast, esophageal reflux was documented in 3 of 4 patients 
with a positive assay. The investigators concluded that detection of pepsin in saliva and/or 
sputum may provide a noninvasive method to test for reflux of gastric contents.
168
 In another 
study in which patients with GERD symptoms were evaluated, sputum/saliva specimens 
collected before bedtime were analyzed by an immunoassay.
 
The test for pepsin was positive in 
20 of the 40 patients.  When the investigators compared the pepsin results to 24 hr pH-metry in 9 
of the patients, the sensitivity and negative predictive value of the pepsin test were excellent. 
However, its specificity and positive predictive value were relatively low.
166
 Knight et al. 
examined pepsin in 63 sputum samples cleared from the back of the throat in 23 subjects with 
known EER and compared results with pH monitoring from a pH esophageal manometry 
catheter. The majority of throat samples (78%) contained no pepsin and was associated with no 
decrease in pH at the esophageal or pharyngeal probe. Fourteen (22%) of the throat samples had 
detectable pepsin. Subjects with samples positive for pepsin had significantly decreased 
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esophageal and pharyngeal pH (p = .01). The researchers reported pepsin immunoassay results 
that were 100% sensitive and 89% specific for EER at the pharyngeal probe.
169
 
In a pilot study, 10 of 50 gastric fed mechanically ventilated patients who were suctioned 
once had pepsin positive oral secretions via western blot analysis.
58
 Mean oral secretion volume 
in orally intubated patients was recently reported to be 7.5 ml with a 2 hr oral suctioning 
frequency.
170
 Oral secretions are easy to obtain and less invasive than esophageal pH monitoring 
and may provide a good biomarker for GER in the critically ill patient and predictor of aspiration.  
In summary, studies have indicated that pepsin is a reliable marker for both reflux and 
pulmonary aspiration. Different techniques for measuring pepsin report different sensitivity and 
specificity. Of the various methods to measure pepsin to detect reflux and aspiration, the western 
blot assay appears to be the optimal method to measure pepsin.  
Conclusion 
Mechanically ventilated gastric fed patients in the ICU are at risk for reflux and 
aspiration. The primary recommendation to reduce reflux and aspiration is HOB elevation to 45
◦
. 
However, studies have demonstrated the challenges to maintaining elevation at 45
◦
.
102-103
 No 
comparative studies of the incidence of reflux and aspiration with analysis of pepsin presence 
according to HOB elevation (30
◦
 versus 45
◦
) were identified in the literature. A study was needed 
to examine the association of reflux and aspiration at the two HOB elevations. This study was 
the first to examine the association between reflux and aspiration in critically ill mechanically 
ventilated gastric fed patients according to a 45
◦
 HOB elevation versus a 30
◦
 HOB elevation.  
Results from the study will provide clinicians with some evidence to support positioning 
practices to reduce risk for reflux and subsequent aspiration in critically ill, mechanically 
ventilated patients who are receiving gastric feedings. Pepsin in oral secretions has been shown 
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to be a reliable marker of reflux. A simple measure of pH of oral secretions at the bedside may 
provide a marker for reflux thus, this study examined pepsin presence in oral secretions and 
association with pH measurements. 
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The primary aims of this study were: 1) to describe the frequency and duration that 
patients’ HOB angles are temporarily lowered for treatment purposes below 30
◦
 or below 45
◦
; 2) 
to describe the occurrence of reflux (pepsin-positive oral secretions) and  aspiration (pepsin-
positive tracheal secretions) with HOB elevation at 30
◦
 and 45
◦
; 3) to determine the association 
between reflux and aspiration with the 2 different HOB elevations in adult ICU mechanically 
ventilated gastric fed patients; 4) to determine the association between a temporarily lowered 
HOB position for treatment purposes and reflux of gastric contents; 5) to determine the 
association between 7 patient characteristics (gender, age, BMI, GRV, sedation level, disease 
severity, and use of prokinetic agents) and reflux; 6) to determine the association between the pH 
(range 0-14) of oral secretions and pepsin presence in oral secretions (the gold standard measure 
of reflux). 
Currently there is minimal research that directly compares HOB elevation of 30
◦
 to 45
◦
 on 
the outcomes of reflux and aspiration in the population of interest. In Chapter III the research 
methodology is presented that was used to address the study aims and research questions.  
Research Design 
The design of the study was a randomized 2-day crossover trial. Subjects were ICU 
mechanically ventilated gastric fed patients that were randomly assigned to 1 of the 2 HOB 
elevation sequences. During the first sequence, the subject’s HOB was elevated at 30
◦
 for 12 hrs 
on day 1 and 45
◦
 for 12 hrs on day 2. In the second sequence, the HOB started at 45
◦
 for 12 hrs 
on day 1 and 30
◦
 for 12 hrs on day 2. A 12-hr washout period was provided to allow for 
elimination of the effects of the first day’s HOB elevation between day 1 and day 2 with the 
bedside nurse positioning the patient per nurse and patient preference. Thirty degree HOB 
elevation was considered usual care in the study setting. Therefore, the experimental condition 
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was implementation of 45
◦
 HOB elevation. Table 1 demonstrates the design with sample size and 
interventions. The independent variable for this study was HOB elevation and the dependent 
variables were reflux and aspiration. 
 
Table 1  
Randomized Crossover Design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Setting 
The study site was an acute care facility that delivers care to adults only. The study was 
conducted in 2 ICUs at Barnes-Jewish Hospital in St. Louis, MO. After Human Institutional 
Review Board (IRB) approval at Washington University and Barnes-Jewish Hospital, an 
umbrella agreement was made with the University of Kansas IRB. Verbal and written approval 
to conduct this study was provided to the Principal Investigator (PI) by the nurse managers and 
medical directors of both ICUs. One unit was a 36 bed surgical/burn/trauma ICU and the second 
unit was a 19 bed medical ICU. Staffing was generally 1 nurse to 2 patients with an occasional 
one-on-one assignment. Internal process improvement data on mechanically ventilated patients 
demonstrated that 30
◦
 HOB elevation was observed in more than 90% of the audits in both ICUs.  
Sample 
Patients were screened Monday-Friday to determine if they met inclusion and exclusion 
RANDOMIZED CROSSOVER 
TRIAL  
 (n = 15)  
Usual Care 
Condition               
Experimental 
Condition 
  
8 am  
  
 
                 HOB  
                 30
◦
 
 
8 pm  
 
8 am        
              
              
      HOB                                                                                            
45
◦
 
  
8 pm  
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criteria. A screening filter to identify all patients with tube feeding orders was developed for both 
ICUs in the electronic medical record (EMR). A list of all patients with tube feeding orders was 
generated each screening day. The list was reviewed 2 times per day to ensure no new orders 
were missed. In addition, discussions with the clinical dietitian in each unit were held to seek 
information about any other possible orders to be placed. The list of patients generated from the 
tube feeding order filter and during dietitian discussions were screened for the following 
inclusion and exclusion criteria. 
The inclusion criteria for subjects to enter the study included: 
1. X-ray confirmed gastric location of feeding tube or surgically/endoscopically placed 
gastric feeding tube prior to study enrollment 
2. Mechanically ventilated per endotracheal tube  
3. ≥ 18 years of age 
4. Approval from attending physician to randomize patient to a 30◦ and 45◦ HOB elevation 
5. Surrogate available to provide written consent 
6. Anticipated mechanical ventilation and tube feeding duration for at least 48 hrs 
The exclusion criteria of patients included: 
1. Oral trauma that would prevent oral suctioning 
2. Inability to tolerate having the HOB at 45◦ for 12 hrs 
3. Elevated intracranial pressure or other reason which precluded suctioning or lowering 
of the patient’s HOB 
4. Stage I or higher pressure ulcer to the sacrum/coccyx, buttock or either trochanter 
region 
5. Pregnancy  
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6. Documented history of GERD or hiatal hernia 
7. Active pulmonary tuberculosis or any airborne infectious disease 
A subject screening form was used to verify all inclusion criteria were met and no 
exclusion criteria were present (Appendix A). A total of 215 patients were screened. Surrogates 
of patients meeting inclusion criteria were approached for informed consent. Study details 
including risks were explained to the surrogate by the PI. Opportunity for the surrogate to ask 
questions was provided during the consent discussion. The surrogate’s understanding of the 
study and the role of the patient in the study was verified with questions by the researcher. The 
surrogate was informed that participation was voluntary, that the patient could be withdrawn 
from the study at any time upon request and that usual care would continue for the patient 
whether the surrogate consented to have the patient participate or not.  
Randomization 
Informed consent was obtained the day before randomization. If the patient remained on 
mechanical ventilation per an endotracheal tube the following morning, the patient was 
randomized to either 30
◦
 or 45
◦
 HOB elevation on day 1 and crossed over to the other HOB 
elevation on day 2. Subjects were maintained in the designated HOB elevation from 0800-2000. 
The washout period was 2000-0800 between day 1 and day 2. Nurses positioned the patient at 
any HOB level during this time period. Randomization of the subjects occurred using a computer 
generated randomization schedule. Cards were labeled with HOB assignment and placed in a 
sealed security envelope. Envelopes were sequentially numbered on the outside. The morning 
after informed consent, mechanical ventilation and continued tube feeding orders were verified 
for each subject. Once verified, the envelopes were sequentially opened the first morning of data 
collection.   
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Data Collection and Procedures 
 Prior to study recruitment, nurses in both ICUs received education on study purpose, 
design, methods and HOB gauge operation by the PI. Education required approximately 15 
minutes and was conducted in the conference room in each ICU division. Approximately 140 
nurses worked in the 2 ICUs. For any nurse not reached in the education, real time education 
occurred at time of study start by the PI. Additionally, the nurse caring for a newly enrolled 
patient was provided verbal information on randomization assignment and an opportunity to ask 
any questions of the PI. At time of enrollment, the patient demographic form was completed 
(Appendix B). 
 One research nurse was employed to assist the PI with provision of the HOB elevation 
intervention and data collection. The research nurse was an ICU nurse from 1 of the study units. 
The research nurse received one-on-one education in detail regarding data collection and 
documentation from the PI. The PI was with the research nurse with the first 2 subjects to ensure 
that the procedure for data collection was completed correctly. During all data collection, the PI 
was available to assist and verify accuracy. The research nurse collected data on 4 data collection 
days. The PI collected the data on all other days.  
An electronic HOB gauge, (Nextronics Patient Position Monitoring System, Toledo, OH), 
was placed on the under surface of the bed frame at the HOB by the PI before 0800 on the first 
day of data collection for each subject. A second device with a digital display component was 
placed by the PI on the top side rail of the bed with the measuring apparatus on the under surface 
of the frame near the recording device to ensure the same measurement placement. Battery 
function was verified in the devices with each new subject enrollment. The gauge provided 
information on degree of HOB elevation at 30-second intervals. With a button push, the nurse 
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could clearly visualize the exact HOB elevation in degrees at the subject’s top side rail. Nurses 
were instructed by the research nurse to use the gauge for exact HOB elevation with any subject 
repositioning. The research nurse also assisted with repositioning of the subject on most 
occasions. During these times and after procedures, the research nurse assisted with return of the 
subject to the assigned HOB elevation. At the end of the 36-hr enrollment period, HOB 
information was downloaded by the PI from the device and entered into a secured computer with 
subject enrollment number.  
A brightly colored sign with HOB study and assignment for the day was suspended above 
the subject’s bed each morning. A different colored sign was used for the different HOB 
assignments. The signs were removed each evening at the end of the 12-hr data collection period. 
These signs provided visual cues to maintain the HOB at assigned level. 
Specimen traps for oral and tracheal secretion collection were labeled with study number. 
Specimen traps and labels were delivered to the subject’s room by the research nurse the 
morning of the first day of data collection and throughout the study period. Study day was 
completed by the research nurse on a row of labels for the day. The nurse collecting the 
specimen circled oral or tracheal and recorded the time of collection. The vast majority of 
specimens were obtained by the research nurse. 
A small, hard sided ice cooler (Playmate® Mini-Cooler, Igloo Products Corporation, 
Katy, TX) filled with crushed ice was delivered to the subject’s room at 0800 and fresh ice added 
at 1400 to store and transport oral and tracheal secretions. Ice was obtained from the ice machine 
within the ICUs. Oral secretion volume with a 4-hr oral suctioning interval was reported to range 
from 1 to 25 ml.
170
 Subjects in the current study with larger secretion volumes required 
suctioning at least every hr while patients with smaller secretion volumes required suctioning 
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less than every hr. It was anticipated that suctioning of oral secretions would be required every 1 
to 2 hrs. Increased or decreased frequency of suctioning interval of oral secretions depended on 
the patient’s volume of secretions. The research nurse or bedside nurse connected an Argyle 
Rigid Yankauer (Kendall
TM
 Covidien, Mansfield, MA) oral suction device to 1 opening of the 
specimen trap and suction tubing to the other opening of the specimen trap. The other end of the 
suction tubing was connected to wall suction set to 100 mm Hg. The Yankauer was placed in the 
oral cavity and moved throughout the oral cavity until no further oral secretions were obtained. 
Subjects with a RASS score of 0 who previously suctioned their own oral secretions were 
allowed to continue self-suctioning. 
Tracheal secretions were obtained via the endotracheal tube by the research nurse or 
subject’s bedside nurse as subject condition warranted, typically every 2-3 hrs. Several tracheal 
secretions were missed when tracheal specimens for culture were obtained or during 
bronchoscopy. For tracheal suctioning, the nurse connected the in-line suction catheter, which 
prevented loss of positive end expiratory pressure during suctioning, (Ballard Medical, Draper 
UT) to 1 opening of the specimen trap and suction tubing to the other opening of the specimen 
trap. The nurse followed the hospital procedure for suctioning. The time and date of specimen 
collection and the location of the specimen, oral or tracheal, was written on the label by the nurse 
suctioning the subject. Labeled secretions were placed in a bag and the bag was wedged in the 
ice in a biohazard labeled cooler at the subject’s bedside. A laboratory technician or the PI made 
hourly rounds to obtain collected specimens and ensured subject’s study number and collection 
date and time were clearly legible. Specimens were initially processed in a research laboratory 
on site at Barnes-Jewish Hospital by a laboratory technician under the supervision of the PI for 
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the first 5 subjects and by the PI for the ten subsequent subjects. Specimen processing details are 
described below under pepsin analysis.  
Study Variables and Measurements 
Variables, method of measurement and frequency of measurement for each variable are 
summarized in Table 2. A detailed description of each variable is provided below. 
Table 2  
Summary of Measurements 
 
HOB Elevation 
A device specially designed for this study, the Nextronics Patient Position Monitoring 
System (Nextronics, Toledo, Ohio), was used to measure and record the subjects’ HOB angles 
throughout data collection. The device was pilot tested on a variety of beds at the study 
institution and found to be reliable on all the beds used in the ICUs prior to data collection. The 
system consisted of 2 components (a battery powered display and processing module, and a 
battery powered with plug in capability small sensor module with a micro storage device disk). 
The storage device obtained a HOB elevation reading every 30 seconds as plus or minus, through 
Study Variables  
Type of Variable Method of Measurement Frequency  
Independent Variable  
Head-of-bed elevation 
 
Nextronics Patient Position 
Monitoring System  
 
 
Every 30 seconds  
Dependent Variables 
Reflux 
Aspiration 
 
Pepsin in Oral Secretions 
Pepsin in Tracheal Secretions 
 
Every 1-2 hrs (8 am-8 pm) 
Every 2-3 hrs (8 am-8 pm) 
Predictor Variables  
Age 
Gender 
Body mass index 
Gastric residual volume 
Level of sedation 
APACHE II score 
 
Prokinetics 
 
 
Medical record 
Medical Record 
Medical Record 
Syringe aspiration 
Medical record 
Medical record 
 
Medical Record 
 
 
Time of admission 
Time of admission 
Time of admission 
Every 4 hrs (8-12-4-8) 
Every 4 hrs (8-12-4-8) 
ICU admission and 24 hrs 
before enrollment 
24 hrs pre and during 48 
hrs of data collection 
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a range of minus 20
◦
 to plus 90
◦
. The device attached to the base of the hospital bed with magnets. 
The device disc was downloaded to a Microsoft Excel file (Microsoft Corporation, Redmond, 
WA) upon data collection completion for each subject. Readings were recorded every 30 seconds 
so that the investigator knew in detail if the HOB deviated from the assigned level (45
◦
 for the 
experimental condition and 30
◦
 for the usual care condition). If the bed position was altered, the 
research nurse determined the reason, either by direct observation or by interviewing the bedside 
nurse. If the patient underwent a procedure or diagnostic test that required HOB positioning 
other than the prescribed elevation for the day, the reason was recorded. A digital readout of the 
HOB elevation was accessible to the bedside and research nurse.  
Pepsin Analysis for Reflux and Aspiration 
The western blot immunologic analysis was used in this study to detect the presence or 
absence of pepsin in oral and tracheal secretions. The western blot immunoassay technique 
detects a pepsin concentration as low as 1 microgram/mL,
163
 with a sensitivity of 93% and a 
specificity of 100%.
164
 In physiologic measures, reliability is a measure of stability of the 
technique over time.
171
 The western blot immunoassay technique detected pepsin in all 
secretions at the 2-hr and 4-hr mark and 91% at the 6-hr mark demonstrating reliability of the 
technique over time.
164
 
Once the secretions were obtained, the bedside nurse or research nurse placed a label 
with the study number and day of study on the specimen trap. In addition, the nurse recorded the 
site, oral or tracheal, and time on the label. The specimen trap was placed in a sealed plastic bag, 
and placed in ice in a cooler marked as biohazards waste. Every hr a laboratory technician or the 
PI retrieved the specimens from the enrolled subjects and carried all the bagged specimens in a 
cooler of ice to the on-site research laboratory. The laboratory was housed in a connecting 
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building that required approximately 5 minutes to walk. In the laboratory, a trained technician or 
PI measured the pH and performed the initial specimen processing. A microvial was labeled with 
the study number, X for oral or T for tracheal, and study day and time with a black sharpie pen. 
Fifteen μL of each secretion was pipetted into a 1 mL microvial mixed with an equal pipetted 
volume of Laemmli Sample Buffer (Bio-Rad Laboratories, Hercules, CA) containing 2-
mercaptoethanol. The samples were then boiled at 100
◦ 
C in a water bath with continuous 
bubbling of water for 5 minutes. After boiling, the samples were frozen to negative 90
◦
 C in a 
freezer in the laboratory.  
A strip of pH paper (pHydrion, MicroEssential Laboratory, Brooklyn, NY) was used to 
measure pH of oral secretions. Secretions from the specimen trap were pipetted onto the pH 
paper. The pH measurement was recorded on a data collection sheet with time, date and study 
number by the laboratory technician or PI (Appendix C). Specimens were placed in an ice cooler 
and delivered to the laboratory for western blot analysis. Recorders of pH were not blinded to 
HOB assignment or obvious reflux episodes. 
The frozen samples were thawed at room temperature and centrifuged at 13.4 K rotations 
per minute for 10 minutes. Supernatant was removed, 5% beta-mercaptoethanol was added and 
the sample was boiled for 10 minutes. Proteins were resolved with Western Blotting techniques 
using 4-20% TGX gels (Bio-Rad Labs Hercules, CA) and transferred onto a nitrocellulose 
membrane paper (Bio-Rad Labs) using a wet tank apparatus (Bio-Rad Labs). The membrane was 
then blocked for 60 minutes in 2.5% milk/PBST, and probed with chicken anti-human pepsin 
antibody diluted 100 fold in 1% milk/PBST overnight. The sample was then rinsed 3 times in 
PBST and labeled with rabbit anti-chicken antibody conjugated to horseradish peroxidase 
(Sigma Chemical, St. Louis, MO) diluted 1:200 in 1% milk/PBST for 90 minutes. After the 
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membrane was rinsed 3 times in PBST, pepsin was visualized using Pierce Ultra TMB Blotting 
solution (Thermo Scientific, Rockford IL) as per manufacturer’s instructions. The blots were 
then washed in water, air dried and the results scanned with a flatbed scanner. Positive controls 
of 15 ng and 30 ng pepsin from human gastric juice were utilized to analyze the human samples. 
Fifteen ng control pepsin is equivalent to 1.5 µg/ml pepsin solution in the samples.
163
 The 
chicken antibody was produced in the laboratory of Dr. Yie-Hwa Chang at St. Louis University 
(St. Louis, MO) who supervised the laboratory technicians conducting the western blot analysis. 
Results of the assays were interpreted by a biochemist blinded to condition assignment or 
any clinical events.  The assay was interpreted as positive if pepsin was detected in the oral 
secretions or tracheal secretions in a concentration ≥ 1.5 µg/ml.
 
Ten percent of the samples were 
randomly selected for test-retest to determine reproducibility of results. The extent of reflux was 
computed as the percentage of oral secretions that were pepsin-positive. Similarly, the extent of 
aspiration was computed as the percentage of tracheal secretions that were pepsin-positive.  
Universal precautions were followed during the collection and handling of the oral and 
tracheal secretions. As part of these precautions, the data collectors wore gloves when obtaining 
specimens. Laboratory technicians wore gloves, oral masks and eye protection when the 
secretions were transferred from the sputum traps to vials for processing and analysis. The 
specimen traps and all contaminated personal protective equipment were disposed of in an 
appropriate container marked for biohazardous waste. The coolers were cleaned with a Hype-
Wipe® Disinfecting Bleach Towelette (Daigger & Company, Inc., Vernon Hills, IL) and allowed 
to air dry overnight between subject uses.   
Age and Gender 
Age (in years) and gender were entered in the EMR by the admitting department. The PI 
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confirmed age with the subject or surrogate and gender by direct visualization. The PI recorded 
both age and gender in the research record. 
Gastric Residual Volume 
Every 4 hrs, the research nurse instilled 30 ml of air into the irrigation port of the gastric 
feeding tube with a 60 ml catheter tipped syringe. Negative pressure was then applied to the 
syringe to allow for withdrawal of gastric contents. The subject’s gastric contents were removed 
and emptied into a calibrated container until no further aspirate could be obtained. Any sample 
greater than 250 ml was discarded and the feeding tube was flushed with 30 ml of water. GRVs 
less than 250 ml were returned to the subject. The feeding tube was flushed with 30 ml of water 
and tube feedings resumed if continuous. In subjects ordered for bolus tube feedings, the 
subject’s bedside nurse was informed of the GRV prior to the next bolus feed. In addition, the 
GRV was documented in the subject’s EMR and the research record (Appendix D). It is standard 
of practice at the study hospital for nurses to measure GRV every 4 hrs per the above procedure.  
Richmond Agitation-Sedation Scale (RASS) 
The Richmond Agitation-Sedation Scale (RASS) is a 10 item clinician scored assessment 
of the patient’s sedation and agitation level (see Table 3 below).
172
 In the study ICUs, the RASS 
was documented every 4 hrs by the bedside nurse in the patient’s EMR. The ICUs have used this 
scale for over four years. The RASS score documented by the bedside nurse was entered into the 
research record every 4 hrs from 0800-2000 on both days. The RASS has reported interrater 
reliability (interclass correlation 0.956-0.964, weighted  0.73 to 0.91); criterion validity (RASS 
compared to neuropsychiatric assessment over time, significant changes identified with both 
methods over time); construct validity (r = 0.78 with Sedation Agitation Scale, -0.78 with 
Ramsay Sedation Scale, 0.78 to 0.91 with Glasgow Coma Scale, 0.93 with visual analog scale) 
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when utilized in both mechanically ventilated and non-ventilated patients for a variety of ICU 
populations. In these studies a high degree of correlation has been demonstrated among multiple 
types of ICU practitioners including nurses, physicians, pharmacist, and neuropsychiatric 
experts.
172-173
 All RASS scores were recorded on the data collection sheet (Appendix D). 
Table 3  
Richmond Agitation-Sedation Scale
172
 
 
Score Richmond Agitation-Sedation Scale 
+4 Combative Overtly combative, violent, immediate danger to staff 
+3 Very agitated Pulls or removes tube(s) or catheter(s); aggressive 
+2 Agitated Frequent non-purposeful movement, fights ventilator 
+1 Restless Anxious but movements not aggressive or vigorous 
0 Alert and Calm  
-1 Drowsy Not fully alert, but has sustained awakening (eye opening/eye 
contact) to voice (>10 seconds) 
-2 Light sedation Briefly awakens with eye contact to voice (<10 seconds) 
-3 Moderate 
sedation 
Movement or eye opening to voice (but no eye contact) 
-4 Deep sedation No response to voice, but movement or eye opening to physical 
stimulation 
-5 Unarousable No response to voice or physical stimulation 
 
Acute Physiology and Chronic Health Evaluation (APACHE II) 
Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity of disease 
classification system that is a point score based on 12 standard physiologic measurements, age 
and previous health condition. The total score ranges from 0-71 with a higher score representing 
higher severity of illness.
174
 Since introduction, the APACHE II has several international studies 
validating its use in ICU patients.
175-177
 Validation was performed with 1,573 admissions in a 
Hong Kong ICU from 1988-1990. Survivors had lower APACHE II scores. Logistic regression 
analysis of mortality and APACHE II demonstrated a close correlation (r
2 
= 0.81).
175
 In a study 
by Del Bufalo et al., predicted mortality with APACHE II was compared to predicted mortality 
with the Simplified Acute Physiology Score (SAPS II) in 306 ICU patients with respiratory 
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disease. The ratio between the actual and predicted hospital mortality was 86% for APACHE II 
and 83% for SAPS II. The receiver operating characteristic curve analysis demonstrated a better 
predictive ability of the APACHE II (80.88%) compared to the SAPS II (73.52%) with a 
significantly larger area under the curve (p < .01).
176  
Lastly, a study of 1,144 patients in a 
medical-surgical ICU compared the APACHE II and APACHE III. Risk assessments showed a 
strong positive correlation between both scores (non-survivors r
2 
= 0.756, p < .001; survivors r
2 
= 
0.787, p < .001). However, risk predictions did not fit uniformly across various disease 
categories with APACHE II predictions better for patients with gastrointestinal disease and 
surgical admissions but similar predictions for medical patients.
177
 
Parameters used to calculate the APACHE II score include temperature; mean arterial 
pressure; heart rate; respiratory rate; oxygenation; serum levels of sodium, potassium, and 
creatinine; hemoglobin; white blood cell count; Glasgow Coma Score, chronic health points and 
age. The APACHE II score was calculated from variables using data from the first 24 hrs of ICU 
admission and 24 hours prior to the first day of data collection. 
Body Mass Index (BMI) 
Obese patients may experience an increase in tLESRs and therefore may be at increased 
risk of reflux and aspiration. BMI was calculated at the time of admission to the ICU when the 
admitting nurse entered the patient’s height and weight. The EMR used a BMI calculator to 
determine the patient’s BMI based on the entered height and weight information. The BMI 
calculated by the EMR was entered in the research record. 
Prokinetics 
The medication administration record in the EMR was checked every 4 hrs for 
administration of any prokinetic agents. The dose and number of doses received for 24 hrs before 
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study inclusion and for the 48 hrs during data collection were documented on the data collection 
sheet (Appendix D). The two major prokinetic agents used at the study hospital were 
metoclopramide and erythromycin. 
Sample Size and Data Analysis 
No studies were identified from which to calculate effect sizes for each of the proposed 
aims and research questions. With the cross over design of 15 subjects, the number of specimens 
collected for each individual and in total was relatively large. Thus, it was assumed that this 
initial study would allow the researchers to detect an effect size for future studies. 
All data entered onto the written research record was entered by the PI into SPSS 18 
(IBM Corporation, Armonk, NY) within 1 week of collection. Upon completion of all data 
collection, all entered results were reviewed for accuracy. Results of western blots were reported 
by subject number, day, time and specimen type by the biochemist. The results were then entered 
into SPSS by the PI and verified twice on subsequent dates. 
For the HOB angles, a Microsoft Excel file was created by the manufacturer that 
converted the radians to degrees of HOB elevation. Data was downloaded from the micro secure 
digital disc from the device within 1 week of data collection. All data from each subject was 
saved in an individual excel file. HOB information from every 30 seconds was retrieved. The 
data was then separated on the Excel file in hourly sheets for both days. All data for the 12-hr 
night washout period were placed on one sheet. The hourly sheets were filtered to obtain angle 
entries less than the assigned level for that day. Minutes less than prescribed was determined. 
Mean values when less than prescribed, overall hourly mean and HOB mean for nights were 
calculated with the Excel average formula. The results were confirmed on two separate dates. All 
results were then entered manually into SPSS 18 and verified again on two later dates by the PI. 
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Non-parametric statistical tests were used to analyze the data due to the small sample size. 
Mean and standard deviation results were determined. For research question 1, the analysis 
included 12 hourly data points for three variables, each measured under the usual care and 
experimental conditions: 1) the number of minutes that the bed was lowered below 30
◦
 (usual 
care) or 45
◦
 (experimental), 2) the average HOB angle when the bed was lowered, and 3) overall 
mean HOB angle for each day. Median differences between total minutes lowered for each HOB 
assignment, mean when lowered less than assigned and overall mean at each assignment were 
examined with related samples Wilcoxon Signed Rank Tests. Also, a 2 X 12 (condition X hr) 
repeated measures Friedman test was used to analyze mean changes over time on the number of 
minutes per hr that the bed was temporarily lowered and the average HOB angle while lowered 
for each HOB assignment. 
For research question 2, descriptive statistics were used to summarize the percentage of 
secretions in which pepsin-positive oral secretions and pepsin-positive tracheal secretions were 
observed across the 12 hrs in the 30
◦
 usual care condition and the 45
◦
 experimental condition. A 
related samples Wilcoxon Signed Rank test was used to compare the usual care and experimental 
conditions on the summary scores for % pepsin-positive oral secretions and % pepsin-positive 
tracheal secretions at each HOB assignment. 
For research question 3, using summary scores from the 15 patients, two Kendall’s tau 
correlation coefficients were computed between % pepsin-positive oral secretions and % pepsin-
positive tracheal secretions. One correlation was computed for the usual care condition and a 
second correlation for the experimental condition. Scatterplots were examined for outliers, 
nonlinearity, and homoscedasticity. Percent of matched samples, oral and tracheal secretions 
simultaneously collected with same results, was also calculated 
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For research question 4, Kendall’s tau was computed using summary scores measuring 
total minutes the HOB was lowered, the average angle during lowered periods, overall mean 
angle and % pepsin-positive oral secretions for the usual care and experimental conditions. In 
addition, scatterplots were examined for the various bivariate relationships. 
To examine the association between patient characteristics and reflux in research 
question 5, Kendall’s tau correlations were computed between each of the patient characteristics 
(gender, age, BMI, GRV, RASS, APACHE II, and use of prokinetic agents) with the summary 
score of % pepsin-positive oral secretions. Scatterplots were also examined. 
For research question 6 to examine the association between pH (range 0-14) of oral 
secretions and pepsin in saliva, Kendall’s tau correlation was computed between the average pH 
of oral secretions (over the 12 hrs) and the summary score of % pepsin-positive oral secretions.  
Scatterplots were also used. In addition, pH measures of 4 and 5 were descriptively compared 
with pepsin results. 
Ethical Considerations 
Human Research Protection Office approval was obtained at Barnes-Jewish Hospital at 
Washington University. A reliance agreement was then obtained between Washington University 
and the University of Kansas prior to study initiation.  
Subject preferences for positioning for comfort were considered. The research nurse 
documented when the HOB was less than the allocated level because of subject request. After 30 
minutes at the lowered position if the subject appeared awake, an attempt was made to elevate 
the subject’s HOB to the randomized level and maintained per subject tolerance. If at any time 
the subject or surrogate wanted to withdraw from the study, the subject would have been 
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immediately removed from any further data collection and the subject positioned for comfort and 
per the nurse’s discretion.  
The subject’s HOB was lowered at any time by the bedside nurses and physicians as the 
clinical situation warranted or during procedures and diagnostic tests. If the subject’s condition 
changed and required lowering of the HOB, for clinical or safety concerns, the bedside nurses 
and physicians could withdraw the patient at any time. Management of the ventilator and 
weaning from the ventilator was performed by the multi-disciplinary ICU team. Removal of the 
endotracheal tube, extubation, was determined by the medical team. Upon extubation, data 
collection stopped. 
The subject may have been at increased risk for pressure ulcers with the HOB elevation 
to 45
◦
. To minimize the risk, research nurses assisted the bedside nurse with turning the subject 
every 2 hrs. During the repositioning, the subject’s skin was assessed at the sacral, buttock and 
greater trochanter regions. Patients on mechanical ventilation in both ICUs are maintained on 
pressure relieving mattresses which lowers the risk of pressure ulcers and was standard of care. 
All study subjects were on a low air loss pressure relieving mattress prior to data collection.  
However, if the subject had demonstrated an alteration in skin integrity, Stage I pressure ulcer 
(redness without blanching upon skin touch), which could be related to the HOB elevation, the 
subject would have been removed from the study. Any reason for subject withdrawal or removal 
from the study was documented on the demographic sheet (Appendix B). 
The other primary risk of this study was a breach of confidentiality. Confidentiality of 
subjects was maintained throughout the study data collection, analysis and reporting. Each 
subject was assigned a code number that was used on all data forms and laboratory specimens. 
The data sheets were kept in a closed binder in the possession of the research nurse at all 
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times. During nights and non-data collection days, the binder was kept in the PI’s locked desk 
in a locked office. Only the PI and the research nurse had access to the subjects’ names and 
code numbers. The master list was kept in the PI’s office in a locked file cabinet. All identifiers 
were destroyed at the completion of the study. As data were entered into an electronic file, a 
password protected computer which was in the locked office of the PI was used. Only the PI 
had access to the electronic files.  
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CHAPTER IV  
RESULTS 
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Sample 
Screening and Enrollment 
After approval from both Washington University and the University of Kansas, the study 
was conducted from August 2012 through January 2013. The EMR was screened for tube 
feeding orders in both participating ICUs to identify potential subjects. Patients were screened 4-
6 days per week based on the inclusion and exclusion criteria. Screening for subjects was not 
completed on certain days because of events occurring in the ICU, such as outside agency 
surveys or unavailability of the PI to review the records for subject screening. 
A total of 215 patients were screened for a final convenience sample of 17 subjects. 
Patient screening and randomization is outlined in Figure 5. The primary reasons for gastric fed 
patients to be excluded were ventilation via a tracheostomy (n = 25) or pre-existing pressure 
ulcers to the sacral/coccyx or buttock areas (n = 24). No patients were excluded for pressure 
ulcers to the greater trochanter regions. A variety of other conditions led to exclusion. For 
example, 8 patients had a high intracranial pressure measured with a subarachnoid bolt which 
prevented suctioning frequency and required HOB elevation maintenance near 45
◦
. Therefore, 
these patients also could also not be lowered to the 30
◦
 position. Conversely, 4 patients were 
gastric fed but were receiving continuous veno-venous hemodialysis requiring vasoactive 
medication to maintain blood pressure and could not be elevated to 45
◦
. Several patients were 
excluded because of contraindications to regular oral or tracheal suctioning: hemoptysis from 
large airway or lung tumors (n = 3); pulmonary or airway instability (n = 3); significant oral 
trauma (n = 5). Five patients were excluded for previous diagnosis of GERD. With the EMR 
screening filter set for any tube feeding order, 72 patients had orders for small bowel feeding and 
thus were excluded from the study.  
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 The PI obtained a total of 17 consents from patients’ surrogates to participate in the study. 
One subject who was consented to be in the study was never randomized due to delay in 
validation of an outside hospital placed gastrostomy tube location. The subject was extubated 2 
days after consent and was never randomized into a study group.  A second subject was 
extubated the morning after consent and thus was never randomized into a study group.  Thus, 
only 15 subjects were randomized to a study group. Validation of feeding tube placement was 
completed via radiograph for nasal or oral placed tubes. Other types of placement (endoscopic or 
surgical gastrostomy tube) were confirmed during the procedure. Information on screening, 
randomization and completion of data collection is outlined in Figure 5. 
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Figure 5  
Patient enrollment, randomization and disposition 
 
 
 
Note: GF, gastric fed; ETT, endotracheal tube; GERD, gastroesophageal reflux disease; ICP, 
intracranial pressure; POA, power of attorney; OR, operating room, HOB, head of bed 
 
Eleven patients completed the entire 36-hr data collection period. For all those who 
completed less than 36 hrs, the reason was due to extubation by the healthcare team. Both ICUs 
Screened for eligibility 
(n=215) Excluded (n=200) 
  2: consented, never randomized 
 11: GF, not ventilated 
 25: GF, ventilated via tracheostomy 
 24: GF, ETT ventilated with pressure 
ulcers 
 72: small bowel fed, ventilated 
  7: GF, anticipated ventilation for < 48 hrs 
  5: GF, GERD 
  3: GF, significant hemoptysis-lung injury 
  5: GF, significant oral trauma 
  8: GF, high ICP 
  4: GF, hemodynamically unstable 
  3: GF, pulmonary or airway instability 
  1: GF, rotating bed, can’t elevate to 45◦ 
  6: GF, respiratory isolation 
  3: GF, missed family on two days 
  7: GF, no family or POA visiting 
  1: GF, < 18 years of age 
  5: GF, goals of care towards comfort 
  4: GF, multiple trips to OR planned 
  4: GF, family declined 
 
Randomized (n=15) 
Randomized to usual care 30
◦
on day 
1 (n=7) 
 6 completed both days 
 1 completed 25 hours 
Randomized to experimental care 45
◦
 on day 
1 (n=8) 
 5 completed both days 
 1 completed 29 hours 
 1 completed 25 hours 
 1 completed 4 hours 
Analyzed 241 hours of data 
150 hours possible at  
prescribed HOB 
Analyzed 238 hours of data 
160 hours possible at  
prescribed HOB 
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conducted a protocol driven daily wake up and spontaneous breathing trial of all intubated 
patients. Although each subject enrolled was expected to remain ventilated for the necessary 2-
day data collection period, there were 2 subjects prior to randomization and 4 subjects 
randomized that were extubated early. All subjects were identified at risk for pressure ulcer 
development with a mean Braden score of 11.9 ± 1.8 and a range of 9-14. Risk for pressure ulcer 
is identified as a score < 18.
178
 No subjects developed a pressure ulcer despite a low Braden 
score. Subjects served as their own controls with the cross over design, hence all data collected 
was included in the analysis. 
Baseline Characteristics 
 Subject characteristics and a description of equipment used to provide care to the subjects 
are shown in Table 4. The mean age of the subjects was 59.6 ± 15.3 years; mean BMI was 33.8 ± 
10.4; mean ICU admission and study admission APACHE were 21.5 ± 9.3 and 18.3 ± 7.9 
respectively. There were no significant differences in the study by gender (8 males, 7 females). 
The majority of subjects were Caucasian (80%); the remaining subjects were African American. 
Almost three-fourths (73%) of the subjects were fed via large-bore Salem Sump (gastric 
decompression tubes).  Two subjects had gastrostomy tubes and 2 had pliable small-bore nasally 
inserted feeding tubes. All subjects received stress ulcer prophylaxis with the majority receiving 
esomeprazole intravenously (47%). No subjects received any prokinetic agents 24 hrs prior to or 
during data collection. Two subjects received continuous infusion of tube feedings; the 
remainder received bolus feeds every 4 hours. As shown in Table 4, all subjects were on low air 
loss pressure relieving mattresses manufactured by Hill-Rom Corporation (Batesville, IN); 
slightly over half (53%) were cared for on the Envision mattress.  Use of pressure relieving 
mattresses and turning every 2 hrs is the standard of care for both units. From the recorded 
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hourly observations of subject position, subjects were turned 154 times out of the 310 possible 
turn opportunities demonstrating every 2-hr repositioning.  Each day resulted in an opportunity 
for 12 repositions. The total of 310 overall possible opportunities was derived from the number 
of subjects with data collected at the start of each hr. Subjects were positioned on their right side 
for 123 (36%) observations, left side for 96 (28%) observations and back for 120 (36%) 
observations. Thus, for a majority of the time (65%) subjects were observed in a side lying 
position. 
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Table 4  
Subject and Baseline Characteristics  
 
Characteristic     Mean ± SD                              Frequency (%) 
Age (years) 59.6 ± 15.3 
Gender: 
     Male 
     Female   
                                                      
                                                         8 (53%) 
                                                         7 (47%) 
Race: 
    Caucasian 
    African American 
 
                                                       12 (80%) 
                                                         3 (20%) 
Intensive Care Unit 
    Surgical                                      
    Medical 
 
                                                 10 (67%) 
                                                         5 (33%) 
 Reason for Admission 
      Trauma 
      Surgery 
      Sepsis 
      Respiratory Failure 
      Liver Failure     
                                                     
                                                         4 (27%) 
                                                         4 (27%) 
                                                         3 (20%) 
                                                         3 (20%) 
                                                         1 (6%) 
Body Mass Index (BMI) 33.8 ± 10.4 
APACHE II: 
    Time of Unit Admission 
    Time of Study Admission 
 
21.5 ± 9.3 
18.3 ± 7.9 
Braden Score 11.9 ± 1.8 
Type of Bed Surface 
    Envision  
    Sport  
    Total Care Bariatric 
    Synergy  
 
                                                         8 (53%) 
                                                         3 (20%) 
                                                         3 (20%) 
                                                         1 (7%) 
Feeding Tube Type 
    Large Bore Salem Sump  
    Small Bore Feeding Tube 
    Gastrostomy Tube 
 
                                                       11 (73.3%) 
                                                         2 (13.3%) 
                                                         2 (13.3%) 
Feeding Tube Size 
    10 Fr               
    12 F 
    14 Fr 
    16 Fr 
    18 Fr 
    22 Fr 
 
                                                         1 (6.7%) 
                                                         1 (6.7%) 
                                                         3 (20%) 
                                                         8 (53.3%) 
                                                         1 (6.7%) 
                                                         1 (6.7%) 
Stress Ulcer Prophylaxis 
    Esomeprazole IV 
    Esomeprazole PT 
    Famotidine PT 
 
                                                         7 (47%) 
                                                         3 (20%) 
                                                         5 (33%) 
Note: IV, intravenous; PT, per (feeding) tube 
  
  
76 
A total of 188 oral secretions were obtained. Missing oral secretions were due to absence 
of oral secretions sufficient to clear the Yankauer suction device. For oral specimens, 106 (56%) 
were pepsin-negative and 82 (44%) were pepsin-positive. A total of 174 tracheal secretions were 
obtained. Missing tracheal specimens were due to bronchoscopy or orders for tracheal culture. 
Sixty-six (38%) tracheal specimens were pepsin-negative and 108 (62%) were pepsin-positive.  
Description of HOB Maintenance at Usual and Experimental Level 
For the first aim, a description of the frequency and duration to which subjects’ HOB 
angles were temporarily lowered for treatment purposes below 30
◦
 or below 45
◦ 
and overall 
hourly mean for each day is provided below. The total time that the HOB was lowered at usual 
care of 30
◦
 was 340.5 minutes with an average of 24 minutes/subject and median of 20.5 
minutes/subject. The total time that the HOB was lowered at the experimental condition of 45
◦
 
was 2236.5 minutes with an average of 149.1 minutes/subject, median 40 minutes/subject. There 
was a significant difference in median minutes lowered between the 2 HOB assignments  
(p = .035). However, the minutes lowered were highly variable for subjects in the 45
◦
 assignment 
day (Figure 6).  A calculation of the percent of time subjects’ HOB levels were maintained at the 
assigned HOB condition was calculated using the total number of minutes the HOB was at 
prescribed level and the total possible minutes for each assignment. Subjects maintained usual 
care 30
◦
 HOB elevation for 96% of the possible minutes and 77% of the minutes at the 
experimental condition of 45
◦
.  
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Figure 6  
Total Minutes the HOB was Lowered for Each HOB Assignment 
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Note: One subject with no data at 30
◦
 assignment 
The mean HOB elevation when lowered was 8.2
◦
, median 8.3
◦
, in the 30
◦
 condition and 
19.4
◦
, median 14.9
◦
, in the 45
◦
 condition (p = .008). Figure 7 displays mean HOB when lowered 
for each HOB assignment.  
Figure 7  
Mean Angle When HOB Lowered Less Than Assigned 
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Note: One subject with no data at 30
◦
 assignment 
The overall mean HOB angle includes the full 720 minutes of data collection available 
for each day (or time in study) and includes the mean angle when lowered. The overall mean 
angle was 30.2
◦
 ± 4.8
◦
, median 28.7
◦
, with a range of 25.7
◦
 to 41.7
◦
 for the usual care hrs. For the 
experimental hrs, the overall mean angle of elevation was 38.6
◦
 ± 3.6
◦
, median 39.2
◦
, with a range 
of 31.9
◦
 to 43.8
◦
. There was a significant difference in overall mean angle elevation between the 
2 HOB assignments (p = .001). Figure 8 demonstrates mean HOB per subject over the data 
collection period for each HOB assignment. 
Figure 8  
Overall Mean of the HOB 
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Note: One subject with no data at 30
◦
 assignment 
Friedman tests were conducted to assess for differences among the mean ranks of the 
hourly minutes that the HOB was temporarily lowered and mean HOB angle when lowered for 
each HOB assignment. Results indicated that minutes lowered and mean HOB levels when 
lowered were not significantly different over time for either usual care or experimental HOB 
assignment. Values for minutes lowered for usual care were χ
2
 (11, n = 12) = 10.7, p = .469.  
  
  
79 
Results for mean HOB angle when lowered less than 30
◦
 were χ
2
 (11, n = 12) = 9.7, p = .554. 
Results for minutes HOB lowered for experimental HOB level were χ
2
 (11, n = 13) = 5.2,  
p = .919. Lastly, values for mean HOB angle when lowered less than 45
◦
 over 12 hours were χ
2
 
(11, n = 13) = 4.75, p = .943.    
The subjects’ HOB levels were lowered 66 times (mean = 4.7/subject) in the usual care 
group and 76 times (mean = 5/subject) in the experimental condition. Thus, subjects did not 
appear to slide more frequently at the experimental 45
◦
 elevation than at usual 30
◦
 elevation. 
Subjects were placed in trendelenburg position on 13 occasions, 11 times for repositioning, once 
for central venous catheter placement and once for central venous catheter removal. A flat HOB 
was used for 1 central venous catheter placement on a patient with a cervical spine fracture.  As 
noted in Figure 7, subject 9 had a mean less than 0 when lowered on the usual care day due to 
central venous catheter removal and use of trendelenburg for repositioning. Trendelenburg time 
for repositioning required an average of 1.75 minutes. Central line removal trendelenburg 
required 5 minutes. The central line placement trendelenburg use required 36 minutes. The low 
number of trendelenburg positioning events was not amenable to statistical analysis. Rather, the 
data were reviewed to determine the pepsin results of oral and tracheal secretions following use 
of trendelenburg. On four occasions, participants had no secretions available the hour after 
trendelenburg positioning. For the other 9 times of trendelenburg use, all subjects had either a 
pepsin-positive oral (5) or tracheal secretion (7). When both specimens were available, 3 (50%) 
were both pepsin-positive (reflux and aspiration); 1 (17%) occasion resulted in a pepsin-positive 
oral secretion and a pepsin-negative tracheal secretion (reflux, no aspiration); 2 (33%) instances 
resulted in pepsin-negative oral secretions and pepsin-positive tracheal secretions (aspiration 
without detected reflux). 
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The specimen pepsin results were examined for conversion from negative to positive 
after use of trendelenburg position. Specimens were not available at the start of the hour for 5 
trendelenburg uses. On 5 occasions, the subject converted from a negative specimen at the start 
of the hr of trendelenburg use to a positive specimen on the next specimen after trendelenburg 
use. On 3 occasions, the specimen was positive at the start of the hr of trendelenburg use and 
remained positive.  
Mean HOB during the night hrs was 33.4
◦
 for the 14 subjects who completed 25 hrs or 
more of the study. Only 1 subject had a mean < 30
◦
 (20.5
◦
) for the 12-hr night period. 
Lowering the HOB for subject repositioning (moving towards HOB and turning) most 
frequently took 0.5-2 minutes however, some repositioning required up to 5 minutes. Reasons for 
lowering other than repositioning included personal care (i.e. incontinence cleaning, baths, 
dressing change), travel to radiology and during CT scan, bedside procedures (i.e. bronchoscopy, 
central venous catheter placement) clinician decision (i.e. atrial fibrillation, bedside dialysis) and 
subject request or sliding. Frequency of reasons for lowering at each HOB assignment, other than 
subject repositioning, as well as hrs lower than assigned due to subject intolerance are outlined in 
Tables 5 and 6. The frequency of HOB lowering events for patient care, procedures, radiology 
and clinical decision was higher in the 45
◦
 assigned hours (n = 24) compared to the 30
◦
 assigned 
hours (n = 18 events).  
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Table 5  
Reasons and Frequencies the HOB was Lowered for Other than Repositioning 
 
REASON HOB LOWERED 30
o 
Assignment 
n 
45
o 
Assignment 
n 
Personal Care 
    Bath with full  linen change 
    Cleaning after stool incontinence 
    Cleaning and fecal containment device placement 
    Dressing change 
    Straight catheterization 
 
7 
3 
0 
1 
1 
 
8 
6 
2 
1 
0 
Bedside Procedures 
    Bronchoscopy 
    Ultrasound 
    Radiograph 
    Central Venous Catheter Placement 
    Central Venous Catheter Removal   
 
0 
0 
1 
1 
0 
 
3 
1 
0 
1 
1 
Clinician Decision 
    Atrial fibrillation bedside cardioversion 
    Bedside dialysis   
 
1 
0 
 
0 
1 
Travel to Radiology for CT scan 3 0 
Total Frequency              18             24 
 
Table 6  
Hours HOB was Lowered for Patient Intolerance 
 
REASON HOB LOWERED 30
o 
Assignment 
n/hrs 
45
o 
Assignment 
n/hrs 
Patient Intolerance 
    Patient requested lower than assigned 
    Patient sliding 
 
0/0 
0/0 
 
     3/20.5 
1/4 
Total Hours 0   24.5 
 
No subjects required invasive cardiac hemodynamic monitoring with a pulmonary artery 
catheter or esophageal doppler monitor. Two subjects experienced hypotension (mean arterial 
pressure < 60 mm Hg) and required initiation of vasopressor medications. The first subject 
developed rapid atrial fibrillation and experienced a decrease in mean arterial pressure to 
approximately 55 mm Hg on the usual care 30
◦
 assignment day. With sedation for cardioversion, 
the mean arterial pressure remained in the low 50’s. A phenylephrine infusion was started at 100 
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micrograms (mcg)/minute. The HOB was lowered for cardioversion and then placed in 
trendelenburg for central line placement, noted as 2 events on Table 5. After placement of the 
central line, the subject remained on phenylephrine infusion of 90-60 mcg/minute throughout the 
remainder of data collection that day. However, the subject was returned to 30
◦
 HOB elevation 
after central line placement and maintained at that angle with slow titration of the phenylephrine 
for the last 4 hrs of data collection. The night mean HOB angle was 33
◦
. The phenylephrine was 
discontinued at 0600 on day 2 and the subject never required vasopressor medication support at 
HOB elevation of 45
◦
. The subject had an overall mean of 42
◦
 for the 12 hrs of day 2 without 
experiencing hypotension. 
The second subject with a sepsis diagnosis was off vasopressor medications for 20 hrs 
prior to the first day of data collection. At 0900 the subject had an increase in temperature to 
40.1
◦
 Celsius, was agitated at a RASS score of +3 and was desaturating to pulse oximetry 
readings of 85%. The subject’s sedation medications of fentanyl and dexmedetomidine were 
increased. Subsequently, the mean arterial pressure dropped to 54 mm Hg and a norepinephrine 
infusion was started at 2 mcg/minute. The infusion continued at that dose for 1.5 hours. The 
HOB was maintained at the assigned 30
◦
 throughout this period except for 1 period of 
repositioning. The subject’s temperature decreased to 38.2
◦
 within 90 minutes of temperature 
peak and returned to 39
◦
 later in the day. The subject’s temperature never rose again above 40
◦
 
and the subject did not require any vasopressor medication for the remainder of data collection. 
No subject requested the HOB to be lowered while at usual care 30
◦
 while 2 subjects 
requested higher HOB on usual care day for more comfortable breathing. Three subjects 
requested the HOB lowered at 45
◦
 assignment. Two of these subjects were primarily at a RASS 
score of 0, alert and oriented, while the third subject was a RASS score of -1. One subject was 
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uncomfortable in the side lying position in the last half of the 12-hr day. The subject was 
maintained at 25-39
◦
 based on her comfort for a mean of 29
◦
 during the lowered minutes. For 2 of 
the hrs, the subject slept at a HOB elevation of 23
◦
 and was not disturbed to raise the HOB 
during the 2 hrs.  
One subject was maintained < 45
◦
 due to discomfort for the entire 12 hrs. This subject’s 
BMI was 38 with central obesity, the majority of excess accumulation of fat in the abdominal 
area. The subject was not on a bariatric bed frame that allowed lowering of the feet which may 
have contributed to the discomfort. The subject’s mean HOB was 36.4
◦
 for the 12 hrs with 1 hr 
means ranging from 35.5
◦
 to 38.4
◦
. It is possible that a bariatric bed at 45
◦
 with the ability to 
lower the foot of the bed would have been more comfortable for the subject. Three other bariatric 
patients with central obesity were able to tolerate 45
◦
 using a bariatric bed that allowed for 
lowering of the feet as the HOB was elevated.  Two subjects with obesity were comfortable at 
45
◦
 with the standard bed frame.  
The third subject who requested HOB < 45
◦
 had multiple traumatic injuries and required 
acclimation to 45
◦
 in the first 2 hrs of data collection. The mean HOB elevation for the first 2 hrs 
was 35
◦
.  The subject was comfortable at 45
◦
 for the remaining 10 hrs.  
Lastly 1 subject with a BMI of 21.7 slid down in bed when the HOB was raised to 45
◦
. 
Therefore, to prevent sliding and friction, the subject was kept at a mean of 35
◦
 which was the 
level observed to stop the sliding. The mean hourly HOB angle ranged from 36.6
◦
 to 34.2
◦
 when 
not lowered for provision of patient care. The highest HOB elevation achieved with this subject 
was 39
◦
 for 45 minutes.  
Description of Reflux and Aspiration Occurrence 
The second aim was to describe the occurrence of reflux (pepsin-positive oral secretions) 
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and aspiration (pepsin-positive tracheal secretions) with HOB elevation at 30
◦
 and 45
◦
. Initially 
obtaining secretions from the oropharynx was planned to measure the occurrence of reflux. 
However, due to the subjects’ alertness with minimal sedation per the RASS scores and concern 
for elicitation of the gag reflex with induction of reflux, secretions only from the oral cavity were 
suctioned instead. Overall 44% of oral secretions were positive and 62% of tracheal secretions 
were positive. Related samples Wilcoxon Signed rank tests were used to compare summary 
scores of percent pepsin-positive oral and tracheal secretions for each HOB elevation. The mean 
percent of pepsin-positive oral secretions was higher at 30
◦
 HOB elevation (48.4 ± 31.3), median 
54, compared to 45
◦
 HOB elevation (32.3 ± 33.2), median 20; however, it was not statistically 
significant (p = .108). The mean percent of pepsin-positive tracheal secretions was also higher at 
30
◦
 HOB elevation (69.4 ± 33.8), median 71, than 45
◦
 HOB elevation (62.5 ± 34.5), median 67, 
and was not statistically significant (p = .366). Figures 9 and 10 present the percent (median and 
range) pepsin-positive oral and percent pepsin-positive tracheal secretions per HOB assignment. 
Figure 9  
Boxplots of Percent of Pepsin-Positive Oral Secretions at Both HOB Elevations 
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Figure 10 
Boxplots of Percent-Positive Tracheal Secretions at Both HOB Elevations 
 
 
 
A pattern in lower frequency of oral secretions during the experimental 45
◦
 HOB 
elevation day was identified. Therefore, an additional related samples Wilcoxon Signed Rank 
Test of frequency of oral secretions comparing 30
◦
 and 45
◦
 elevation was conducted. The median 
frequency of oral secretion, (mean, SD, median) 8.5 ± 3.6, 9.5 at 30
◦
 and 5.7 ± 3.2, 5, at 45
◦
, was 
significantly lower at 45
◦
 (p = .035).  
Association between Reflux and Aspiration 
The third aim was to examine the association between reflux and aspiration with the 2 
different HOB elevations in adult ICU mechanically ventilated gastric fed patients. There were 
142 paired samples of an oral secretion obtained at the same time as a tracheal secretion. A slight 
majority (60%) had the same results while 40% of the samples had different results. Table 7 
summarizes the descriptive relationship of the paired samples. 
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Table 7  
Results of Paired Oral and Tracheal Samples 
 
Pepsin + oral 
Pepsin + tracheal 
Reflux and 
aspiration 
n (%) 
Pepsin – oral 
Pepsin – tracheal 
No reflux or 
aspiration 
n (%) 
Pepsin + oral 
Pepsin – tracheal 
Reflux without 
aspiration 
n (%) 
Pepsin – oral 
Pepsin + tracheal 
Aspiration without 
reflux 
n (%) 
45 (32%) 39 (27%)  15 (11%)  43 (30%)  
Matched 84 (60%) Unmatched 58 (40%) 
 
The scatterplot of percent pepsin-positive tracheal secretions in relationship to percent 
pepsin-positive oral secretions at 30
◦
 demonstrated a non-linear relationship. Kendall’s tau  
(τ = -.362, p = .089) correlation was not significant at usual condition. The scatterplot of the 
experimental condition was random and the correlation results were not significant as well,  
(τ = -.037, p =. 864).  
Tracheal pepsin-positive secretions were also examined in relationship to positive oral 
secretions 1 hr and 2 hrs prior to the positive tracheal specimen. When available 1 hr before a 
positive tracheal secretion, the oral secretion was positive 14 times and negative 14 times. When 
an oral specimen was available 2 hrs before a pepsin-positive tracheal specimen, the oral 
secretions were negative 38 times and positive 30 times. Thus, no relationship was observed with 
the delayed results as well. 
Two subjects had observed reflux based on tube feeding appearance of oral secretions.   
Subject 4 had 12 ml of oral secretions with tube feeding appearance obtained with the Yankauer 
suction device at 1000 and 5 ml obtained at 1100 on the usual care day, 30
◦
. The 1000 time was 
shortly after return from CT scan and a prolonged period of lying flat, being moved from bed to 
table to bed and then repositioning for linen change. The subject’s oral and tracheal secretions 
were both positive for the next 6 hrs. After the 6 hrs, the subject had 1 more pepsin-positive oral 
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secretion 9 hours after observed reflux and a final negative oral and tracheal specimen. An 
example of the pattern of specimens associated with the reflux event is presented in Table 8. The 
previous day at experimental condition, the patient had all negative oral secretions and two 
positive tracheal secretions. 
Table 8  
Specimen Results Log for One Subject with Observed Reflux  
 
Hour Pepsin Results Oral Secretions Pepsin Results Tracheal Secretions 
0800                 - (negative) + 
0900                 + (positive) + 
1000: reflux noted + + 
1100: reflux noted + no specimen 
1200 + + 
1300 no specimen no specimen 
1400 + + 
1500 no specimen no specimen 
1600 no specimen no specimen 
1700 no specimen no specimen 
1800 + - 
1900 no specimen no specimen 
2000 - - 
 
Subject 12 had tube feedings infusing on usual care day at 0900. At that time 5 ml of 
secretions with tube feeding appearance were suctioned from the oral cavity and obvious emesis 
was cleaned from the subject’s face, gown and cervical collar.  Prior to the observed reflux and 
emesis, at 0800 the subject’s oral secretions were negative and tracheal secretions were positive. 
At 0900 both oral and tracheal secretions were positive and remained positive for the next 
several hours. Oral secretions remained positive for 4 hrs, tracheal secretions remained positive 
for 9 hrs. Subject 12 also required trendelenburg for central line placement at 1545 on the same 
day. The final oral and tracheal secretions at 2000 were negative. Table 9 demonstrates the 
pattern of specimens associated with reflux for this subject. 
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Table 9  
Specimen Results Log for Second Subject with Observed Reflux  
 
Hour Pepsin Results Oral Secretions Pepsin Results Tracheal Secretions 
0800                  - (negative) + 
0900: reflux noted                 + (positive) + 
1000 + + 
1100 + no specimen 
1200 + + 
1300 + no specimen 
1400 - + 
1500: trendelenburg no specimen no specimen 
1600 - + 
1700 no specimen no specimen 
1800 - + 
1900 no specimen no specimen 
2000 - - 
 
Lowered HOB and Reflux 
The fourth aim was to determine the association between a temporarily lowered HOB 
position for treatment purposes and reflux of gastric contents. Minutes HOB was lowered, mean 
when HOB lowered and overall mean were correlated with percent pepsin-positive oral 
secretions for each HOB assignment. Scatterplots demonstrated a non-linear pattern for mean 
minutes HOB lowered at 30
◦
 and a linear pattern at 45
◦
 however with several outliers. However, 
both Kendall’s tau correlations were not significant. Scatterplots demonstrated a non-linear 
pattern for mean HOB angle when less than assigned HOB for each condition. Both Kendall’s 
tau correlations were not significant. Mean HOB angle and percent pepsin-positive oral 
secretions at both HOB assignments were linear with a few outliers and did not demonstrate 
homoscedasticity. Both Kendall’s tau correlations demonstrated a significant moderate to large 
negative correlation (Table 10).  
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Table 10 
Correlations of Minutes and Mean Less than HOB Assignments and Overall Mean at each HOB 
Elevation and Percent of Pepsin-Positive Oral Secretions 
 
Relationship Kendall’s 
tau 
τ value 
Significance 
2-tailed 
p value 
Minutes < 30
◦
 and % pepsin-positive 
oral secretions 
.158 .461 
Minutes < 45
◦
 and % pepsin-positive 
oral secretions 
.092 .668 
Mean when lowered < 30
◦
 and % 
pepsin-positive oral secretions 
-.092 .668 
Mean when lowered < 45
◦
 and % 
pepsin-positive oral secretions 
-.010 .959 
Overall mean HOB Day 30
◦
 and % 
pepsin-positive oral secretions 
-.536 .008* 
Overall mean HOB Day 45
◦
 and % 
pepsin-positive oral secretions 
-.433 .026* 
* p < .05 
Association of Subject Characteristics and Reflux 
The fifth aim was to determine the association between 7 patient characteristics (gender, 
age, BMI, GRV, sedation level, disease severity, and use of prokinetic agents) and reflux. As 
previously noted, 8 men and 7 women participated in the study. The mean age of the participants 
was 59.6 ± 15.3 years. The mean BMI was 33.8 ± 10.4. Three subjects were of normal weight 
(BMI 18-25), 3 subjects were overweight (BMI 25-29.9), 7 subjects were obese (BMI 30-39.9) 
and 2 subjects were obese class III (BMI >40) often described as morbid obesity.
179
  
A total of 103 GRV measurements were obtained. The average GRV was 59.4 ± 68.1 
with a range of 0-440 ml. GRV was measured as less than 100 ml for 82 (82%) measurements. 
Eight GRVs were ≥ 250, 4 obtained in 1 subject, 2 in another subject and 1 each in 2 subjects. 
GRVs were separated into 4 categories based on volume. Figure 11 illustrates the frequency of 
each GRV category as percentage of total GRV measurements. 
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Figure 11  
Frequency of Gastric Residual Volume (GRV) in Categories 
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RASS scores ranged from +3 to -5 with a mean of -1.2 ± 1.2.   Mean ICU admission and 
study admission APACHE were 21.5 ± 9.3 and 18.3 ± 7.9 respectively. No subjects received 
prokinetic agents; therefore, no analysis could be performed. 
Kendall’s tau correlations were conducted for each of the 6 subject characteristics with 
data. There were no significant relationships of gender, age, BMI, GRV and APACHE II with 
percent of pepsin-positive oral secretions. A significant negative correlation was observed with 
RASS sedation scores. Scatterplots demonstrated a linear pattern without homoscedasticity. As 
sedation deepened (higher negative RASS score), the percent of pepsin-positive oral secretions 
increased. Table 11 displays all correlation results for subject characteristics and percent pepsin-
positive oral secretions. 
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Table 11  
Correlations of Subject’s Characteristics and Percent Pepsin-Positive Oral Secretions 
 
Relationship Kendall’s 
tau:  
τ value 
Significance 
2-tailed 
p value 
Gender and % pepsin-positive 
oral secretions 
.290 .202 
Age and % pepsin-positive oral 
secretions 
-.155 .427 
BMI and % pepsin-positive oral 
secretions 
-.337 .083 
GRV and % pepsin-positive oral 
secretions 
.329 .091 
RASS and % pepsin-positive 
oral secretions 
-.429 .028* 
APACHE II and % pepsin-
positive oral secretions 
.020 .920 
* p < .05 
Oral Secretion pH and Pepsin Measurements to Detect Reflux 
The final aim was to determine the association between the pH (range 0-14) of oral 
secretions and pepsin presence in oral secretions (the gold standard measure of reflux). The 
range of pH measurements was 4-8 with a mean of 6.3 ± .05. All subjects received oral care at 
approximately 0900 with 0.7% sodium monoflurophosphate toothpaste and tooth brushing 
followed by .12% chlorhexidine gluconate oral rinse.
180
 Chlorhexidine gluconate oral rinse has a 
pH range of 5-7.
181
 All subjects were receiving acid-suppressant medication, thus, only results 
for pH measurements of 4 and 5 were hand matched with the pepsin result. Eight subjects had no 
pH measurements less than 6. Seven subjects had at least 1 pH measurements equal to 4-5 for a 
total of 49 measures. Oral secretion pH measurements in 4 subjects were at pH 4-5 for the 
majority of the oral secretions, ranging from 65%-100% of their secretions, and accounting for 
44 (90%) of the specimens with a pH of 4-5. Oral secretion pH was 5 at 0900 and 1000, near the 
time of oral care, in only 1 subject which was also the time of observed reflux in this subject. 
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Nineteen (39%) of measurements were associated with pepsin-positive oral secretions. Table 12 
displays the pH measurements and matched oral secretion pepsin results. With the 3 observed 
reflux events, pH was 5 for 1 specimen and 4 for the 2 specimens in the same subject. 
Table 12  
pH Measurements and Associated Oral Secretions Pepsin Results 
 
Immunoassay for Pepsin in Oral Secretions   
 total number of specimens with pH < 6 =  49 
pH 4 
n  
pH 5 
n  
Pepsin-positive 12  7  
Pepsin-negative 24 6 
 
The scatterplot demonstrated a non-linear relationship of average pH and overall percent pepsin-
positive oral secretions. The Kendall’s tau correlation (τ = -.135, p = .487) was not significant. 
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CHAPTER V 
DISCUSSION, IMPLICATIONS, CONCLUSION 
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The primary aims of this study were: 1) to describe the frequency and duration that 
patients’ HOB angles are temporarily lowered for treatment purposes below 30
◦
 or below 45
◦
 2) 
to describe the occurrence of reflux (pepsin-positive oral secretions) and  aspiration (pepsin-
positive tracheal secretions) with HOB elevation at 30
◦
 and 45
◦
; 3) to determine the association 
between reflux and aspiration with the 2 different HOB elevations in adult ICU mechanically 
ventilated gastric fed patients; 4) to determine the association between a temporarily lowered 
HOB position for treatment purposes and reflux of gastric contents; 5) to determine the 
association between 7 patient characteristics (gender, age, BMI, GRV, sedation level, disease 
severity, and use of prokinetic agents) and reflux, 6) to determine the association between the pH 
(range 0-14) of oral secretions and pepsin presence in oral secretions (the gold standard measure 
of reflux). Data from 15 patients, 11 who completed both days of a randomized cross over design, 
were analyzed to address each aim. This chapter includes a discussion of the results of the study, 
implications for nursing practice, recommendations for future research and limitations of the 
study.  
HOB Elevation 
 Previous research demonstrated difficulties with obtaining 45
◦
 HOB  
elevation
18, 20, 100,
 
103-105
 and at times 30
◦
 HOB elevation in ICU patients.
182-183
 In the current 
study, HOB elevation at 30
◦
 was maintained for 96% of all possible minutes and HOB elevation 
at 45
◦
 was maintained for 77% of all possible minutes. While HOB elevation at 30
◦
 was 
maintained for significantly more minutes than 45
◦
 elevation, this study demonstrated that many 
patients can maintain greater than 30
◦
 elevation and near 45
◦
 elevation without any significant 
change in the frequency of lowering of the bed to reposition the patient due to sliding. The 
Friedman test results for minutes lowered than assigned HOB elevation and mean angle when 
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lowered were not significantly different over the 12 hour period for each HOB assignment. 
Therefore, patients generally tolerated (comfortable and not sliding) both conditions over the 
entire day at each HOB elevation. At the experimental condition, 2 subjects did not tolerate 45
◦
 
HOB elevation over the full period of data collection (uncomfortable or sliding) and 2 subjects 
requested a lower HOB elevation for some hrs and tolerated 45
◦
 for other hrs. One subject was 
comfortable initially however, requested the HOB lowered in the last 4 hrs. Another subject 
requested the HOB lower than 45
◦
 for the first 2 hrs and then was comfortable the remaining 10 
hrs near 45
◦
.  
 The mean HOB when lowered was significantly higher for the 45
◦
 experimental hrs 
compared to the 30
◦
 usual condition hrs. This may be explained by the elevations for patient 
comfort or sliding prevention near 30
◦
. In addition, during the 4 hrs of dialysis for 1 subject, the 
HOB elevation was at 30
◦
 rather than 45
◦
 for the entire dialysis treatment.  
Maintenance at assigned HOB elevation was achieved with the assistance of several 
interventions. Bright signs with HOB assignment for the day were suspended at the bottom of the 
subjects’ monitors and provided a continuous visual reminder. In addition, the nurse researcher 
was at the bedside during data collection and was able to assist with repositioning and provided a 
verbal reminder of the HOB assignment. Lastly, a one button click digital readout of the HOB 
elevation allowed for accurate measurements and assisted with returning patients to the assigned 
HOB elevation after repositioning, patient care and procedures.  
Night time HOB elevation was a mean of 33.3
◦
. Only 1 subject was maintained at less 
than a mean of 30
◦
 for the 12-hr washout period during the night. All night nurses were aware of 
the subjects’ participation in the study however no signs or reminders to maintain HOB elevation 
at 30
◦
 or higher were provided during the 12-hr washout period. The gauge with HOB digital 
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display remained on the bed for the nurses to use which may have helped with maintenance of 
30
◦
 elevation during the night.  
Beds with incorporated accurate digital measurement readings could provide an easy 
method to assist nurses with HOB positioning to maintain elevation at ≥ 30
◦ 
and up to 45
◦
. Rose 
et al. found that the use of a bed measurement device initially improved HOB elevation to 45
◦
. 
However, the device did not improve HOB elevation to 45
◦ 
over a sustained 6 month period. 
Nevertheless, maintenance of the HOB to 30
◦
 was sustained throughout the 6 month period.
102 
The results of the current study confirmed that the VAP prevention standard of care for HOB 
elevation was 30
◦
 at the study site. Previous research identified difficulty with maintaining 
30
◦
.
182-183 
However, implementation of VAP prevention guidelines in both units for more than 5 
years may explain the high compliance with HOB elevation maintenance at 30
◦ 
observed in the 
current study during data collection and during the night time washout period. 
Reasons for HOB lowering were similar to findings from previous researchers; however 
not all of the concerns expressed in previous surveys were identified in the current study.
22,105,183
  
Delivery of personal care was the most frequent reason found for HOB lowering. The American 
Association of Critical-Care Nurse’s VAP prevention practice alert recommended elevating 
HOB after these procedures as soon as feasible.
22
 In a survey by Helman et al., ICU nurses 
identified probability of the patient sliding down in the bed as the primary concern with HOB 
positioning to 45
◦
.
105
 In the current study, only 1 subject had problems with sliding at 45
◦
 
elevation. Mean frequency of lowering HOB per subject was similar in both HOB assignment 
groups; therefore, sliding at the higher 45
◦
 angle does not appear to be an issue. Another reason 
cited by Helman and colleagues was patient discomfort at 45
◦
. Three subjects requested HOB to 
be decreased less than 45
◦
 for comfort but each subject tolerated elevation higher than 30
◦
. The 
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other 2 reasons cited in the survey included concerns over increased skin breakdown and 
hemodynamic monitoring.
105
  
No patients in this study developed an alteration in skin integrity. Turning patients 
regularly to relieve pressure and prevent pressure ulcers has been a standard practice 
recommendation for over 150 years.
184
 However, in the side lying position at 30
◦
, interface 
pressures ≥ 32 mm Hg may occur in healthy adults. Interface pressures above 32 mm Hg is the 
point at which tissue hypoperfusion is believed to occur.
185
 Therefore, regular repositioning of 
ICU patients is necessary. In a review of the practice of every 2-hr turning, Hagisawa and 
Ferguson-Pell reviewed the evidence which supports this practice. The authors identified that 
studies initially conducted with animals demonstrated microscopic changes with 70-100 mm Hg 
of applied pressure for 2 hrs.  The authors also discussed a study of tissue tolerance of tissue over 
bony prominences in humans that suggested acceptable tolerance was maintained for up to 2 hrs. 
In addition, the authors reviewed a study of pressure-induced ischemia on tissue metabolism that 
identified recovery of glucose and ATP within 30 minutes of pressure relief after 2 hrs of 
sustained pressure but not after 4 hrs. Hagisawa and Ferguson-Pell concluded that no strong 
scientific evidence was found to explain the 2-hr turning interval in humans.
184
  However, 
turning every 2 hrs remains the standard of care in ICUs and was associated with reduction of 
pressure ulcers compared to non-routine every 2-hr turning.
186-187
 Research has also shown the 
benefit of pressure relieving mattresses to prevent pressure ulcers in ICU patients.
188-189
  In the 
current study, the use of pressure relieving mattresses and turning patients every 2 hrs per 
institution protocol were important interventions in preventing pressure ulcer development at the 
sacral, ischial and trochanter regions. Thus, despite the concern for pressure ulcer risk with HOB 
elevation > 30
◦
, the current study demonstrated the safety of HOB elevation near 45
◦
 for 12 hrs in 
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this sample population with pressure ulcer prevention measures in use. Further study is needed 
with a larger sample size and for longer time periods of HOB elevation at 45
◦
 to validate this 
finding. The potential to reduce reflux and aspiration with a HOB elevation > 30
◦
 without 
increased pressure ulcer rates is an important intervention that should be examined with various 
populations and settings. 
In a descriptive study of HOB angle in cardiothoracic ICU patients, Ballew et al. found 
that the strongest factor associated with a lower backrest elevation was administration of a 
vasopressor medication (p = .001). Subjects receiving vasopressor medication support had a 
mean backrest elevation of 19
◦
 compared to 26
◦
 for subjects not receiving any support. They also 
found that a mean blood pressure of 64 mm Hg or less without vasopressor medication support 
was associated with a significantly lower mean HOB angle of 17
◦
 compared to 24
◦
 (p = .01) for 
patients with a mean blood pressure > 65 mm Hg. HOB angle was measured with a protractor, 
line-of-site angle indicator, plumb line, and plumb bob.
183
 
In the current study, no subjects had invasive cardiac hemodynamic monitoring and 2 
subjects experienced hypotension with a mean blood pressure < 60 mm Hg. Other than the 
cardioversion and central line placement in 1 subject, both subjects were maintained at 30
◦
 
elevation during vasopressor medication infusion and ultimate discontinuation. Also both of 
these subjects tolerated 45
◦
 elevation on the second day without requirement of vasopressor 
medication support. Data from these 2 subjects provide initial evidence that HOB elevation at 30
◦
 
can be maintained despite vasopressor medication support requirement. Further investigation is 
needed on HOB elevation and vasopressor medication administration. Use of a continuous 
electronic device as used in the current study would provide more comprehensive data to analyze 
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the impact of HOB angle elevation with patients experiencing hypotension or requiring 
vasopressor medication support. 
A bariatric repositioning algorithm described trendelenburg positioning to facilitate 
moving the bariatric patient up in bed.
106
 The primary reason for trendelenburg positioning in the 
current study was for repositioning of bariatric subjects. Trendelenburg positioning for longer 
time periods were needed for central venous catheter placement and removal. The impact of 
trendelenburg position in all subjects with a specimen available the hour following a negative 
HOB trendelenburg angle resulted in a pepsin-positive oral or tracheal secretion or both. On 5 of 
the 10 occasions when specimens were available, the previous specimen was negative. On 3 
occasions the previous specimen was also positive and on 5 occasions no specimen was available. 
Thus, use of trendelenburg positioning appears to have a positive relationship with reflux and 
aspiration in gastric fed patients. More data are needed for any statistical analysis but these pilot 
results warrant the need for further investigation of use of trendelenburg in gastric fed patients. 
Additionally, exploration of interventions to reduce reflux and aspiration when trendelenburg 
positioning is required, central line placement and removal, could reduce the risk of reflux and 
aspiration. For example, prior to extended period of trendelenburg for procedures, the impact of 
emptying the patient’s stomach via suction and deep oral suctioning could be examined. The use 
of distal small bowel feeding in relationship with trendelenburg could also be examined.  
The majority of the subjects were overweight or obese in this study. However, use of 
trendelenburg for repositioning was highly variable by nurse and subject position in relationship 
to the distance the subject’s head was away from the top of the bed. The use of ceiling lifts to 
facilitate repositioning of all patients, including obese patients, using a flat HOB to prevent the 
use of trendelenburg could be explored. Previous research has examined the impact of ceiling 
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lifts for turning, repositioning and mobilization to a chair or stretcher for patients in an ICU and 
extended care facilities.
190-192 
Silverwood and Haddock implemented ceiling lifts in an ICU and 
found a decrease in nurses’ self-reported fatigue, pain and frustration levels. In addition, the 
authors also found a decrease in doctors’ visits, medication use and time off due to injury from 
patient care and transfer tasks. Workers compensation claims also decreased by 70%.
190
 In 
extended care facilities, a significant decrease in worker compensation claims secondary to 
musculoskeletal injury from patient care and transferring was found.
191-192
 Future studies could 
examine the impact of ceiling lifts without trendelenburg use for ICU patient repositioning to 
decrease reflux and aspiration events without increasing the risk of injury to bedside clinicians. 
Description of Reflux and Aspiration Occurrence 
Both reflux and aspiration occurred frequently with the majority of oral and tracheal 
secretions being pepsin-positive. For oral specimens, 82 (44%) were pepsin-positive and 108 
(62%) tracheal secretions were pepsin-positive. While the mean scores of percent of pepsin-
positive oral and tracheal secretions were higher at usual care (30
◦
) than experimental care (45
◦
), 
neither Wilcoxon Signed Rank Tests were significant. As this was an initial study, a larger 
sample size in the future may detect a significant difference.  The lower percent of pepsin-
positive oral and tracheal secretions at the experimental condition is consistent with previous 
findings that found semi-recumbent positioning (45
◦
) compared to supine positioning led to 
lower aspiration and pneumonia rates compared to supine.
97-99, 102
 Furthermore, Metheny et al. 
found that elevations to a mean HOB angle of 38
◦
 led to a reduction in aspiration compared to a 
mean elevation of 24
◦
.
96 
The only other study to compare 45
◦
 and near 30
◦
 (25
◦
) found a 25% 
reduction in VAP rate with the higher HOB angle. The findings were not significant due to the 
small sample size.
10
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In earlier tests of pepsin presence in tracheal secretions in an animal model, pepsin was 
detected for up to 6 hrs after a forced aspiration.
164
 Known time of aspiration is difficult in 
patients unless obvious reflux or vomiting is detected. Furthermore, length of time pepsin can be 
detected in oral secretions is unknown. Pepsin results of oral and tracheal secretions from the 2 
subjects with observed reflux episodes provide some insight that oral and tracheal secretions in 
humans may remain positive for several hours after a reflux and aspiration event. Therefore, it is 
difficult to exactly describe the frequency of a new reflux and aspiration event occurrence unless 
there is a negative result followed by a return to positive.  
The percent of pepsin-positive tracheal secretions at 62% was considerably higher than 
previous studies of adult ICU patients.
14,96
 Using the same western blot technique to detect 
pepsin used in the current study, 31% of 6000 tracheal specimens were pepsin-positive. Forty 
percent of patients were fed via the small bowel and the mean HOB angle was 24
◦
. Specimens 
were obtained at the discretion of the bedside nurse.
14 
A later study by the same researchers with 
HOB elevation > 30
◦
 (mean 38
◦
), with 72% use of small bowel feedings and a GRV management 
algorithm resulted in only 12% pepsin-positive tracheal secretions.
96
 Suctioning was again at the 
discretion of the bedside nurse. Previous studies of small bowel feedings, mid-distal duodenum 
or jejunal, were shown to decrease reflux, microaspiration and VAP.
130-133
 All patients in the 
current study were gastric fed which may partially explain the higher percent of pepsin-positive 
tracheal secretions obtained compared to studies using some or the majority of small bowel 
feedings. It is also feasible as discussed earlier that multiple sequential pepsin-positive tracheal 
secretions represented 1 aspiration event and resulted in the high percent of pepsin-positive 
tracheal secretions. The lower percent (44%) of pepsin-positive oral secretions may represent a 
faster clearance of pepsin from oral secretions or failure of reflux to reach the oral cavity.  
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Oral secretions were pepsin-positive in 44% of the samples. Other researchers have found 
different reflux rates with several different techniques to detect reflux in mechanically ventilated 
patients including pepsin,
58,193
 esophageal pH measurement
57
 and radio-isotope levels.
130
 Pepsin 
was found in oral secretions of 7 subjects and 55% of specimens (11/20) in a descriptive pilot 
study of 10 patients.
193
 A difference in the sensitivity level of the pepsin analysis technique may 
lead to variation in results reported as positive. 
In another descriptive pilot study of 50 gastric fed mechanically ventilated patients 
suctioned once for both oral and tracheal secretions, 10 subjects (20%) demonstrated pepsin-
positive oral secretions.
58
 Nind and colleagues used an esophageal pH electrode placed 5 cm 
above the LES to detect reflux in mechanically ventilated ICU patients rather than pepsin; pH 
was measured before and for 5 hrs with a nasogastric feeding. Forty-six acid reflux episodes 
were recorded with a range of 0 to 8 per patient.
57
 Heyland et al. used measurements of radio-
isotopes in oropharynx secretions to detect reflux. Mechanically ventilated ICU patients were 
administered a radio-isotope labeled enteral feed, gastric or post-pyloric.  Hourly samples were 
obtained from the oropharynx and trachea for 6 hrs. GER was defined as an increase in 
radioactivity > 100 counts per minute/g. Gastric fed patients had 39.8% of oral specimens 
positive for regurgitation.
130
 This rate of reflux is comparable to the rate of 44% found in the 
current sample population.  
Two studies of outpatients with or without known GERD measured pepsin in oral 
secretions. In 14 patients with known GERD, 108 saliva and sputum (patient coughed into 
specimen cup) specimens were collected over 24 hrs during esophageal pH monitoring at home. 
Specimens were collected every 2 hrs when awake and when they had coughing or reflux 
symptoms. Samples were not collected in the first hr after a meal. Only 10% of sputum and 
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saliva specimens were pepsin-positive, exact breakdown of each was not reported.
167
 The second 
study examined 40 patients with suspected GERD and 8 healthy volunteers without GERD 
symptoms, no erosive esophagitis on esophagogastroduodenoscopy and no pathologic reflux on 
24-hour esophageal pH monitoring. Sputum and saliva was collected by the patient at bedtime 
and upon awakening in all patients. Patients with suspected GERD were instructed to collect 
sputum and saliva specimens with symptoms as well. In the patients with suspected GERD, 22% 
of saliva and sputum specimens were pepsin-positive, percent of each specimen type was again 
not specified. None of the healthy volunteers had pepsin-positive specimens.
168
  
Several reasons and risk factors may explain the higher percent of pepsin-positive oral 
secretions found in this study compared to the 2 studies of alert patients at home with GERD 
symptoms and the descriptive studies by Schallom et al. and Sole et al. 
58,193
 In this investigation, 
multiple oral secretions over each 12-hr period were obtained for each subject. It is unknown 
how long pepsin can be detected in oral secretions after a reflux episode. The 44% pepsin-
positive oral secretion rate is similar to findings in the study by Heyland et al. where oral 
secretions were obtained hourly for 6 hrs that found reflux in 39% of oral secretions.
130
 Also, no 
control of secretion obtainment and tube feeding administration was performed. Oral secretions 
were obtained hourly when there was sufficient volume. Two subjects received tube feedings 
administered by continuous infusion. For bolus fed subjects, oral specimens may have been 
obtained during, just after or up to 4 hours after a bolus infusion. Other factors are known to 
increase the risk of reflux in the ICU gastric fed population compared to GERD patients at home. 
Straining with coughing induced by suctioning of the endotracheal tube or spontaneous coughing 
is associated with reflux in ventilated patients and would not be seen in home patients.
57
 Also, 
the presence of a tube traversing the esophageal sphincters has been associated with reflux which 
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were not present in the study of GERD patients at home.
59-61
 Delay in gastric emptying and 
altered duodenal motility which results in duodenal gastric reflux has also been demonstrated in 
critically ill patients compared to healthy individuals.
41, 78-80
 Additionally, the risk factor of BMI 
and sedation levels of ICU patients will be discussed later. The multiple risk factors observed in 
the study sample and the high frequency of oral specimen sampling may account for the high 
percent of pepsin-positive oral secretions. 
Association between Reflux and Aspiration 
No relationship was observed between percent of pepsin-positive oral and tracheal 
secretions. Obtainment of oral secretions changed in the study protocol during data collection. 
Initially, obtainment of secretions from the oropharynx was proposed. EER includes gastric 
content reflux to the pharynx, larynx and oral cavity. Sole and colleagues suctioned the 
oropharynx of orally intubated patients with a deep suction catheter and retrieved greater than 5 
ml of secretions. Sedation level was not reported in the sample. No report of gagging was 
reported. A deep suction catheter was used.
170
 A pilot study using the same suctioning technique 
to measure pepsin and amylase of oral secretions was conducted on 10 patients by the same 
researchers and again no gagging was observed.
193
 However, instrumentation of the oral cavity 
and pharynx can stimulate the gag reflex. In healthy adults, Hughes and Wiles initiated the gag 
reflex by depression of the tongue with a stick, touching of the soft palate or touching of the 
pharyngeal wall. Retching was the second most frequent symptom secondary to gag reflex 
stimulation.
194
 Retching can lead to gastroesophageal reflux and vomiting. Gagging is a 
protective reflex to prevent unwanted entry into the mouth and pharynx. During dental 
procedures, stimulation of the gag reflex occurs from stimulation of the oral cavity or pharyngeal 
area. The higher the classification of gagging problem index, the more often IV sedation or 
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general anesthesia was required.
195
 In critically ill neurologic patients, absence of a cough or gag 
reflex was an independent risk factor for acute lung injury/acute respiratory failure most likely 
related to the impaired neurologic activity.
196
 Therefore, less sedation with maintenance of the 
gag reflex is important to prevention of aspiration but stimulation of the gag reflex can lead to 
more reflux.  
The first subject in the current study was sedated at a RASS score range of -4 to -1 with a 
mean score of -2.5. Suctioning of the oropharynx was conducted. However, subjects 2 and 3 
were predominantly alert throughout the data collection period. Subject 2 had a mean RASS 
score of 0.375 while subject 3 had a RASS score of 0 at every assessment. Subject 2 
demonstrated the gag reflex during oral suctioning. To prevent gagging and inducing reflux of 
these subjects, only the oral cavity was suctioned. After this observation, only the oral cavity was 
suctioned in the remaining 12 subjects to be consistent and prevent induction of reflux. It is 
highly likely that EER was missed by suctioning only the oral cavity. Therefore, the association 
between reflux and aspiration may be inaccurate with the revised method of oral secretion 
obtainment from the oral cavity only. Although a large number of oral and tracheal secretions 
were pepsin-positive, frequently tracheal secretions were pepsin-positive while oral secretions 
were pepsin-negative. It is feasible that if secretions were obtained from the oropharynx, a 
significant relationship may have been found. A Yankauer suction device was used in this study 
which might have stimulated the gag reflex compared to a smaller, softer suction catheter. In 
future studies, the use of a small, soft suction catheter may allow improved access to the 
oropharynx without stimulation of the gag reflex and more accurate identification of refluxed 
secretions in the critically ill patient. 
  
  
106 
In the pilot study by Sole and colleagues, specimens were obtained at baseline and then 
1-4 hrs later on 10 subjects for a total of 20 specimens. Seven patients were being gastric fed and 
3 post-pyloric. The researchers found that 35% of matched oral and tracheal specimens were 
both negative, 35% were both positive; 20% were positive for reflux and negative for aspiration 
and 10% were negative for reflux and positive for aspiration.
193
 The higher rate of reflux without 
aspiration found by Sole et al. compared to results from this investigation may be attributed to                          
their use of a small oropharynx suction catheter to obtain secretions from the oropharynx. In the 
current study secretions were obtained with the Yankauer suction device with suctioning of the 
oral cavity only. However, similar patterns of reflux and aspiration were observed in both studies. 
Reflux and aspiration were detected simultaneously the majority of the time. However, at other 
times, reflux was not detected and aspiration was present or reflux was present and aspiration 
was not detected. 
Additionally, the frequency with which secretions were obtained may partially explain 
the lack of relationship between tracheal and oral secretions. In a pilot study, subjects were 
suctioned at only 1 time point. The 2 pepsin-positive tracheal secretions were both associated 
with pepsin-positive oral secretions.
58
 The potential difference in length of time pepsin is 
detected in oral compared to tracheal secretions may have impacted the relationship. In an 
animal model, pepsin was detected for 6 hrs after forced aspiration.
164
 It is feasible that oral 
secretions were measured as negative with no further reflux yet the tracheal secretions remained 
positive for 6 hrs.   
Effect of Lowered HOB on Reflux and Aspiration 
Correlations of the mean minutes the HOB was lowered and the mean HOB angle when 
lowered at each HOB assignment with percent pepsin-positive oral secretions were not 
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significant. However, the overall mean HOB angle for each assignment was significant. A lower 
mean HOB angle was associated with a higher percent of pepsin-positive oral secretions and an 
increased yield of oral secretion obtainment. No studies previously examined the impact of 
intermittently lowering the head of bed on gastric reflux, defined in this study as minutes lower 
than assigned elevation. Rather most studies have examined intermittent observations of HOB 
elevation and the association of aspiration and pneumonia.  
The significant association of mean lower HOB and increased reflux is consistent with 
findings that a lower HOB was associated with increased aspiration and VAP rates.
96-102  
The 
findings from the current study provide the foundation for demonstrating the association of 
reflux and HOB elevation. However, more research is needed with a larger sample size.  
Association of Subject Characteristics and Reflux 
 Of the 6 patient characteristics examined, only sedation level was significant with the 
non-parametric Kendall’s tau. A deeper sedation level was associated with an increased percent 
of pepsin-positive oral secretions. A more sedate patient and a lower level of consciousness as 
risk factors for aspiration and VAP have been reported in several studies.
14,82-83 
As sedation 
levels deepen, the cough reflex is diminished thus clearing of refluxed material
 
may be delayed 
or absent. In this study, the sample was too small for analysis of interactions between variables. 
However, when considering the results of the lower frequency that oral secretions were obtained 
at the experimental HOB condition, it is possible that gravity facilitated clearing of refluxed 
material independent of sedation level. Gravity is known to assist with clearance of reflux in 
upright positions.
4,32
  
The Kendall’s tau correlation was not significant for BMI. Previous research indicated 
that tLESRs were observed in patients with morbid obesity at a rate similar to patients with 
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known GERD.
53
 Thus, patients are expected to have a higher percent of pepsin-positive oral 
secretions with increased BMI. The mean BMI fell in the range of obesity. Therefore, the small 
sample size of predominantly overweight and obese patients may have strongly impacted the 
findings. Additionally, the predominance of overweight and obese patients could partially 
explain the high percent of pepsin-positive oral secretions. Also, sedation levels and HOB levels 
may explain the 2 outliers observed in the scatterplot of BMI and percent pepsin-positive oral 
secretions. The 2 subjects with the highest BMI were alert throughout most of the data collection 
and maintained their HOB elevation assignment or higher throughout data collection. Both 
subjects were in the experimental group where the 45
◦
 HOB was assigned on Day 1. Mean HOB 
was 44
◦
 and 43
◦
 on day 1, 44
◦
 and 37
◦
 overnight and 42
◦ 
and 37
◦
 on usual care day. Both subjects 
were comfortable with the higher HOB elevation and preferred to be higher than 30
◦
 because of 
easier breathing.  Both of these subjects had no positive oral secretions despite frequent pepsin-
positive tracheal secretions. It is likely that these subjects were refluxing to the level of the 
pharynx and larynx with aspiration without refluxing into the oral cavity. Another possibility is 
they were clearing secretions from their oropharynx by swallowing or with the aid of gravity and 
refluxed secretions did not reach the oral cavity.  
No significant correlations were found with age, gender and APACHE II scores. One 
study found liquids emptied more slowly in women compared to men. All women were pre-
menopausal.
43
 In the current study, only 1 female was pre-menopausal. Aging was associated 
with delayed gastric emptying associated with high lipid laden soup compared to non-lipid 
soup.
44
 No studies on aging and delayed gastric emptying with tube fed patients were found. 
Also both the gender and aging studies examined the outcome of gastric emptying and not 
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reflux.
43-44
 The characteristics of age and gender were not associated with increased reflux in the 
current study. 
Previous research of GRV and aspiration found variable results because of different 
methods to detect aspiration and diagnose pneumonia.
113-117
 Studies have demonstrated that GRV 
is higher in the first few days of tube feeding.
111-112
 In this investigation, most subjects were 
consented the first or second day of tube feeding orders yet the GRV was < 100 ml for the 
majority of the measurements. GRV measurement with the syringe method is highly variable 
depending on patient position, tube material, tube type and location in stomach.
107-109
 Subjects in 
this study had a variety of gastric tube sizes and types. Also position for GRV measurement was 
not controlled. Thus, the accuracy of GRV measurements may have varied.  
In the current study, the average GRV was 59.4 ± 68.1 with a range of 0-440 ml. GRV 
was measured as less than 100 ml for 82 (80%) measurements. In a study by Metheny and 
colleagues, GRVs greater than 250 ml were associated with a higher rate of aspiration 
pneumonia.
115
 However, a recent study by Reignier et al. examined absence of GRV monitoring 
in mechanically ventilated gastric fed patients on VAP rates. Intolerance to enteral nutrition was 
defined as observed regurgitation and vomiting without GRV measurement in the intervention 
group. Intolerance to enteral nutrition was defined as GRV measures greater than 250 ml, 
observed regurgitation and vomiting in the control group. Regurgitation events during 
procedures associated with the vomiting reflex, such as oral care, were not counted. The study 
excluded a large number of patients due to a past history of abdominal surgery in the past month 
and feeding via a gastrostomy tube. Patients were maintained at 30
◦
 to 45
◦
. However, there was 
no information on how HOB was measured and recorded. Intolerance was higher in the control 
group while the proportion of patients who vomited was significantly higher in the intervention 
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group. Also there were more reported vomiting episodes in the intervention group. There was no 
significant difference in the primary outcome of VAP rate between groups. VAP rates were high 
in both groups, 16.7% in the intervention and 15.8% in the control group.
197
 The higher number 
of vomiting episodes when GRV was not monitored in the study by Reignier et al. would suggest 
that a potentially higher GRV may be associated with more reflux. However, the researchers 
concluded non inferiority of absence of GRV monitoring due to no difference in VAP rates.
197
   
In this study, a total of 8 GRVs were ≥ 250 ml. One subject had 4 GRVS ≥ 250 ml. This 
subject had 78% pepsin-positive tracheal secretions and 62% pepsin-positive oral specimens. 
The small sample of subjects and small number of GRVs ≥ 250 ml may have resulted in the no 
significant findings. However, due to the controversy over the use of GRV, more accurate 
measures of GRV are needed. Studies related to ultrasound measurement of gastric volume in the 
preoperative setting have shown clinical utility
124-125
 and warrant investigation in the critically ill 
tube fed patient population. 
Oral Secretion pH and Pepsin Measurements to Detect Reflux 
 In the 1970’s a clinical syndrome of gastric bleeding termed “stress ulceration” was 
described in ICU patients. Several medications are administered to prevent this syndrome 
including proton pump inhibitors (PPI), histamine 2 receptor antagonists (H2RA) and sucralfate. 
These medications aim to maintain pH above 3.5-5 to prevent gastric mucosal injury and 
bleeding.
198
 All subjects in this study received either a PPI or H2RA medication throughout the 
data collection period. In addition all subjects received .12 % chlorhexidine gluconate oral rinse, 
pH 5-7, at approximately 0900. The pH of saliva ranges from a pH of 6.4-7.8  Therefore, pH 
measures of oral secretions < 6 were considered indicative of reflux. The lowest pH observed 
was 4. No association was found in the correlation of pH and pepsin measure.  
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Measurement of ambulatory esophageal pH is the gold standard for detection of 
pathologic reflux.
4
 Studies of esophageal pH monitoring in ICU patients were all conducted with 
probes just proximal to the LES.
65, 80, 155  
Traditional distal esophageal pH monitoring may miss 
pharyngeal reflux.
199
 Yuskel and Vaezi stated that ambulatory pH monitoring lacks the 
sensitivity and specificity to detect laryngopharyngeal reflux and that hypopharyngeal and 
proximal esophageal pH monitoring have sensitivity and specificity of only 40% and 55% 
respectively.
200
  
 In this study, the oral cavity was suctioned for secretions and subsequent measurement 
of pH and presence of pepsin. Some chronic conditions can lower salivary pH such as 
hypertension and hypothyroidism yet the pH does not lower below 6.5.
201-202
  Therefore, the 
reason some subjects with a pH of 4-5 demonstrated no pepsin while others with a pH of 4-5 had 
pepsin-positive oral specimens is not entirely clear. The majority of pH measurements of 4-5 
(90%) were obtained in 4 subjects. It is possible that these subjects were refluxing to the 
oropharynx which lowered the pH of oral cavity secretions. Pepsin presence not detected in 
secretions from the oral cavity may have been detected in secretions from the oropharynx. Other 
possible reasons for low pH in the absence of pepsin include faster clearance of pepsin from oral 
secretions than acid clearance and medications that were not recorded. Based on these findings, 
pH measurements of oral secretions from the oral cavity are not indicated as a marker for gastric 
reflux in oral secretions in mechanically ventilated gastric fed patients. Research on 
oropharyngeal secretions may result in a more accurate measure of pH as an indicator of EER. 
Limitations of the Study 
The major limitation of the study was the small sample size. Although percent pepsin-
positive oral and tracheal secretions were lower at experimental 45
◦
 condition, the sample was 
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likely underpowered to detect a significant difference.  A power analysis was conducted on the 
results from the 10 subjects with at least a 9
◦
 difference in HOB elevation from day 1 to day 2. A 
sample of 56 subjects per HOB assignment would be needed at p = .05 level and power of .80 to 
detect a difference in reflux occurrence. A sample of 249 subjects per HOB assignment would be 
needed at p = .05 level and power of .80 to detect a difference in aspiration occurrence.  
The sample also included a high number of obese patients which may have prevented 
detection of differences in subject characteristics. Only 11 patients completed all 36 hrs of data 
collection which may have impacted the results as well. Additionally, some subjects had little 
variance of mean HOB angles on both days. 
The second important limitation was the use of oral secretions from the oral cavity rather 
than the oropharynx. This may have impacted the results of the association between reflux and 
aspiration and pH and pepsin-positive oral secretions. RASS scores near 0 and the risk of 
inducing the gag reflex and producing reflux limited the ability to obtain oropharyngeal 
secretions. A study with a different suction catheter for the oropharynx is needed. 
Implications for Practice and Future Research Directions 
Despite the small sample size, several findings have implications for caring for the 
mechanically ventilated gastric fed patient. First, patients can be maintained at higher HOB 
angles without sliding and without pressure ulcer development when turned regularly and 
maintained on low air loss mattresses. It is feasible to maintain patients near 45
◦
 for extended 
periods although further research is needed with a larger sample and for a longer period of time 
at the elevated HOB angle. Several patients were excluded from the study because they could not 
have the HOB lowered, for example patients with elevated intracranial pressure measurements. 
A descriptive study with the continuous HOB angle measuring device in that patient population 
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could provide evidence on the impact of maintenance of HOB elevation above 30
◦
 for prolonged 
periods on pressure ulcers. Another group of patients was excluded due to concerns for 
hemodynamic instability when elevating HOB above 30
◦
. In this study, 2 subjects were on 
vasopressor medications with the HOB at 30
◦
 and were able to remain in the study. Although 
more research is needed, the automatic response of critical care clinicians to lower the HOB with 
use of vasopressor medications needs to be further investigated. 
Most patients are comfortable with the higher HOB elevations or may require some 
acclimation, as 1 subject in the current study required, to a higher HOB angle when previously 
maintained < 45
◦
. Bariatric patients, especially with central obesity, may be most comfortable at 
higher HOB elevations with a bariatric bed that allows for lowering of the foot of the bed into 
more of a chair position.  
Minutes lowered < 30
◦
 or 45
◦
 and mean angle when lowered may not be significant but 
replication of the study in a larger population is needed. However, the association between 
higher mean HOB angles and lower reflux with both usual care and experimental condition 
implies that gastric fed patients should be maintained at as high a HOB elevation as the patient is 
comfortable. Also the use of trendelenburg positioning appears to be a risk for reflux. This is the 
first study to report trendelenburg positioning, reflux and aspiration events. For repositioning of 
bariatric patients, a study of overhead lifts to assist with turning and repositioning in the bed to 
eliminate trendelenburg use is needed. 
Regarding patient characteristics, GRV was not significant although most GRVs in this 
study were low. Findings discussed from previous studies demonstrated an increase in reflux, 
aspiration and pneumonia with higher GRVs. Findings in the literature are inconsistent due to the 
inaccuracy of GRV measurements by the syringe method. However, if a patient has a GRV ≥ 
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250 ml, it is optimal to elevate the HOB greater than 30
◦
 to reduce reflux as much as possible 
until GRV measurements are lower. Also research of a more accurate method to measure GRV at 
the bedside is needed. Lastly, the current study found that deeper sedation levels were associated 
with increased percent of pepsin-positive oral secretions. Thus, patients who are moderately to 
deeply sedated would probably benefit from higher HOB elevations to decrease reflux.  
Recent studies offer 3 new areas of research in this field.
203-205
 Yuksel and colleagues 
reported on the use of a noninvasive rapid salivary pepsin lateral flow device using 2 monoclonal 
antibodies specific to human pepsin. The device is capable of detecting pepsin in saliva 
secretions within 15 minutes. Expectorated saliva was obtained from 58 subjects with known 
GERD and 51 control patients. The specimens were not read immediately but rather citric acid in 
the collection tube was used to delay degradation of pepsin and the samples were stored on ice 
and refrigerated. The samples were vortexed and centrifuged to obtain supernatants and then 
processed for analysis with the lateral flow device. Pepsin was detected in saliva in 19 (17%) 
samples overall, 13/58 (22%) with known GERD and 6/51 (12%) in the controls.
203
 Additional 
research is needed on the rapid salivary pepsin lateral flow device. Further development of a 
rapid test to detect pepsin in oral secretions could be beneficial to detecting reflux promptly in 
gastric fed patients. Hence interventions, such as placement of a distal small bowel feeding tube, 
could be instituted in patients who cannot maintain HOB elevation and are frequently having 
gastric reflux. 
Two meta-analysis studies have shown that the use of subglottic secretion drainage 
reduces VAP
153-154
 However, use of special endotracheal tubes has not been fully accepted 
primarily due to the expense and unpredictability of knowing which patients will require 
mechanical ventilation for > 72 hours. A new device that continuously clears oral secretions by a 
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saliva ejector was examined in a pilot study by Chow and associates. The device was originally 
used in dental surgery. It has a spiral head with five holes for suction on the inner rim with a 
distal saliva ejector connected to suction. The device was placed between the patient’s check and 
teeth and connected to 100 mg Hg suction. Thirteen patients used the continuous oral suction 
device, 3 developed VAP; 12 patients received standard care, 10 developed VAP.
204
 Overall, the 
reported VAP rate was high despite patients reported to be maintained at 30
o
 HOB elevation and 
implementation of other VAP prevention interventions. The reduction in VAP in the continuous 
oral suction device group warrants further study in a larger population. The device reduces 
aspiration of contaminated oral secretions yet its ability to remove gastric reflux is uncertain 
based on its position in the oral cavity. 
A third study examined the detection of amylase in bronchoalveolar lavage (BAL) 
specimens. Amylase is secreted in saliva and by the pancreas thus amylase in tracheal secretions 
could identify aspiration of oral secretions and duodenogastric secretions. BAL amylase levels 
significantly increased as the number of pre-intubation risk factors increased such as vomiting, 
swallowing dysfunction and altered level of consciousness. From these findings, the authors 
suggested that BAL amylase levels could be used as a screening tool of patients suspected of 
aspiration.
205
 Further study of amylase in oral and tracheal secretions in gastric fed patients is 
needed. 
Conclusions 
In conclusion, this study provides initial evidence that HOB elevation > 30
◦
 is feasible in 
many patients and was associated with decreased percent pepsin-positive oral and tracheal 
secretions and significantly decreased frequency of oral secretions without development of 
pressure ulcers. Lower mean HOB angles as well as deeper sedation levels were associated with 
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a significantly higher frequency of reflux. Additionally, reflux was observed after trendelenburg 
positioning. The associations of reflux and aspiration with elevation to 45
◦
 compared to 30
◦
 and 
trendelenburg positioning require additional research with a larger sample. 
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Appendix A Subject Screening Form 
Inclusion Criteria: 
 
 Yes No 
X-ray confirmed gastric location of feeding tube or 
surgically/endoscopically placed gastric feeding tube 
  
Mechanically ventilated per endotracheal tube   
≥ 18 years of age   
Approval from attending physician to elevate HOB to 45
o
   
Surrogate available to provide consent   
Anticipated mechanical ventilation and tube feeding duration 
of at least 48 hrs 
  
 
If all of the above items are answered yes, screen for the below exclusion criteria 
 
Exclusion Criteria: 
 Yes No 
Oral trauma that would prevent oral suctioning   
Inability to tolerate 45
o
 HOB elevation   
Elevated ICP or condition that would prevent tracheal 
suctioning q 2 hours  
  
Stage I or higher pressure ulcer to sacrum/coccyx, buttocks 
or greater trochanter regions 
  
Planned procedures outside of the ICU in the next 48 hours   
Pregnancy   
History of GERD or hiatal hernia   
Active pulmonary tuberculosis or any airborne infectious 
disease 
  
 
If all of the above items are answered no, approach surrogate for consent. 
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Appendix B Subject Demographic Form 
 
Subject Number: ______________________ 
 
Admitting Diagnosis: _____________________________________________ 
 
 Date 
Hospital Admission 
 
 
ICU Admission 
 
 
Data Collection Start 
 
 
Data Collection Complete 
 
 
 
Check or Enter Information 
Unit 
Medical ICU □ Surgical ICU □ 
Gender 
Male  □ Female  □ 
Age in years at time of enrollment 
 
  
Apache II score from the 24 hrs prior 
to data collection 
  
BMI at time of admission 
 
  
Type of Gastric Feeding Tube 
Salem Sump □ Soft Small Bore □ 
 
PEG Tube  □ Other: Describe 
Size of Gastric Feeding Tube  
___________French 
 
 
Patient Completed 
both days of data 
collection 
Yes   □ No  □  
If no what was the 
reason?  
Patient/Family 
withdrew from study  
□ 
Researchers withdrew 
patient due to change in 
skin integrity  
□ 
 
Caregiver withdrew 
patient due to 
change in patient 
condition □ 
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Appendix C pH Measurements 
 
Subject Number____________ 
 
Date Time pH Measurement 
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Appendix D Data Collection Sheet 
Subject Number____________  Date Started ____________________________ 
 
Day 
1 
         
Hour Oral 
Secretions 
Hourly 
(check 
hour 
obtained) 
Tracheal 
Secretions 
q 2 hrs 
PRN: 
(check 
hour 
obtained) 
GRV 
08-12-
16-20 
RAS
S 
08-
12-
16-20 
Prokinetic 
Agent 
given: 
Enter dose, 
route 
TF 
Flow 
Rate 
ml/hr 
Skin 
Check 
08-20 
and 
each 
turn 
Position 
B-R-L 
Comment 
0800          
0900          
1000          
1100          
1200          
1300          
1400          
1500          
1600          
1700          
1800          
1900          
2000          
Day 
2 
         
0800          
0900          
1000          
1100          
1200          
1300          
1400          
1500          
1600          
1700          
1800          
1900          
2000          
 
Check box when completed. 
Record prokinetics administered for 24 hours prior to data collection. □ 
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